Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Diabetes

  Free Subscription


Articles published in Diabetologia

Retrieve available abstracts of 693 articles:
HTML format



Single Articles


    February 2025
  1. LIN YK, Ye W, Hepworth E, Agni A, et al
    Characterising impaired awareness of hypoglycaemia and associated risks through HypoA-Q: findings from a T1D Exchange cohort.
    Diabetologia. 2025;68:433-443.
    PubMed     Abstract available


    January 2025
  2. MENDOZA K, Barquera S, Tobias DK
    Targeting ultra-processed foods for prevention of type 2 diabetes: state of the evidence and future directions.
    Diabetologia. 2025 Jan 18. doi: 10.1007/s00125-025-06358.
    PubMed     Abstract available


  3. LINGVAY I, Benamar M, Chen L, Fu A, et al
    Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial.
    Diabetologia. 2025 Jan 17. doi: 10.1007/s00125-024-06348.
    PubMed     Abstract available


  4. CHEN Z, Qian F, Liu B, Zong G, et al
    Monounsaturated fatty acids from plant or animal sources and risk of type 2 diabetes in three large prospective cohorts of men and women.
    Diabetologia. 2025 Jan 14. doi: 10.1007/s00125-024-06353.
    PubMed     Abstract available


  5. PACHECO LS, Tobias DK, Haslam DE, Drouin-Chartier JP, et al
    Sugar-sweetened or artificially sweetened beverage consumption, physical activity and risk of type 2 diabetes in US adults.
    Diabetologia. 2025 Jan 8. doi: 10.1007/s00125-024-06351.
    PubMed     Abstract available


  6. HIRVELA L, Haukka J, Keski-Rahkonen A, Sipila PN, et al
    Eating disorders among people with and without type 1 diabetes: incidence and treatment in a nationwide population-based cohort.
    Diabetologia. 2025 Jan 4. doi: 10.1007/s00125-024-06346.
    PubMed     Abstract available


  7. CHIMIENTI R, Torchio S, Siracusano G, Zamarian V, et al
    A WFS1 variant disrupting acceptor splice site uncovers the impact of alternative splicing on beta cell apoptosis in a patient with Wolfram syndrome.
    Diabetologia. 2025;68:128-151.
    PubMed     Abstract available


  8. FU Q, Dai H, Shen S, He Y, et al
    Interactions of genes with alcohol consumption affect insulin sensitivity and beta cell function.
    Diabetologia. 2025;68:116-127.
    PubMed     Abstract available


  9. AHN M, Dhawan S, McCown EM, Garcia PA, et al
    Beta cell-specific PAK1 enrichment ameliorates diet-induced glucose intolerance in mice by promoting insulin biogenesis and minimising beta cell apoptosis.
    Diabetologia. 2025;68:152-165.
    PubMed     Abstract available


    December 2024
  10. NADEAU KJ, Arslanian SA, Bacha F, Caprio S, et al
    Insulin clearance at randomisation and in response to treatment in youth with type 2 diabetes: a secondary analysis of the TODAY randomised clinical trial.
    Diabetologia. 2024 Dec 20. doi: 10.1007/s00125-024-06327.
    PubMed     Abstract available


  11. COLE A, Weight N, Misra S, Grapsa J, et al
    Correction: Addressing disparities in the long-term mortality risk in individuals with non-ST segment myocardial infarction (NSTEMI) by diabetes mellitus status: a nationwide cohort study.
    Diabetologia. 2024 Dec 20. doi: 10.1007/s00125-024-06337.
    PubMed    


  12. SHAPIRO MR, Tallon EM, Brown ME, Posgai AL, et al
    Leveraging artificial intelligence and machine learning to accelerate discovery of disease-modifying therapies in type 1 diabetes.
    Diabetologia. 2024 Dec 19. doi: 10.1007/s00125-024-06339.
    PubMed     Abstract available


  13. WERNROTH ML, Kennedy B, Fall K, Nguyen D, et al
    Bereavement and type 1 diabetes in childhood: a register-based cohort study in Sweden.
    Diabetologia. 2024 Dec 19. doi: 10.1007/s00125-024-06340.
    PubMed     Abstract available


  14. BITARAFAN V, Anjom-Shoae J, Rezaie P, Fitzgerald PCE, et al
    Dose-related effects of intraduodenal quinine on plasma glucose, glucoregulatory hormones and gastric emptying of a nutrient drink, and energy intake, in men with type 2 diabetes: a double-blind, randomised, crossover study.
    Diabetologia. 2024 Dec 18. doi: 10.1007/s00125-024-06344.
    PubMed     Abstract available


  15. KRISTENSEN FPB, Domazet SL, Nielsen JS, Stidsen JV, et al
    Elevated risk of infection in individuals with hyperinsulinaemic type 2 diabetes: a Danish 12 year cohort study.
    Diabetologia. 2024 Dec 11. doi: 10.1007/s00125-024-06342.
    PubMed     Abstract available


  16. PERKINS BA, Turner LV, Riddell MC
    Correction: Applying technologies to simplify strategies for exercise in type 1 diabetes.
    Diabetologia. 2024 Dec 11. doi: 10.1007/s00125-024-06317.
    PubMed    


  17. SMEIJER JD, de Vries ST, Kohan DE, Hou FF, et al
    Sex differences in response to the endothelin receptor antagonist atrasentan in individuals with type 2 diabetes and chronic kidney disease: a post hoc analysis of the SONAR trial.
    Diabetologia. 2024 Dec 11. doi: 10.1007/s00125-024-06326.
    PubMed     Abstract available


  18. DE VRIES ST, Pena MJ, Tye SC, Peters SAE, et al
    Sex differences in the efficacy of angiotensin receptor blockers on kidney and cardiovascular outcomes among individuals with type 2 diabetes and diabetic kidney disease: post hoc analyses of the RENAAL and IDNT trials.
    Diabetologia. 2024 Dec 10. doi: 10.1007/s00125-024-06325.
    PubMed     Abstract available


  19. MOSER O, Zaharieva DP, Adolfsson P, Battelino T, et al
    The use of automated insulin delivery around physical activity and exercise in type 1 diabetes: a position statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPA
    Diabetologia. 2024 Dec 10. doi: 10.1007/s00125-024-06308.
    PubMed     Abstract available


  20. BROWN ME, Thirawatananond P, Peters LD, Kern EJ, et al
    Inhibition of CD226 co-stimulation suppresses diabetes development in the NOD mouse by augmenting regulatory T cells and diminishing effector T cell function.
    Diabetologia. 2024 Dec 5. doi: 10.1007/s00125-024-06329.
    PubMed     Abstract available


  21. MACKENBACH JD, Stuber JM, Beulens JWJ
    Evidence on the effectiveness and equity of population-based policies to reduce the burden of type 2 diabetes: a narrative review.
    Diabetologia. 2024 Dec 2. doi: 10.1007/s00125-024-06330.
    PubMed     Abstract available


  22. JONES DL, Kusinski LC, Gillies C, Meek CL, et al
    A critique of measurement of defective insulin secretion and insulin sensitivity as a precision approach to gestational diabetes.
    Diabetologia. 2024 Dec 2. doi: 10.1007/s00125-024-06334.
    PubMed     Abstract available


  23. VIRTANEN JK, Hantunen S, Kallio N, Lamberg-Allardt C, et al
    The effect of vitamin D(3) supplementation on the incidence of type 2 diabetes in healthy older adults not at high risk for diabetes (FIND): a randomised controlled trial.
    Diabetologia. 2024 Dec 2. doi: 10.1007/s00125-024-06336.
    PubMed     Abstract available


  24. CHEN Y, Torta F, Koh HWL, Benke PI, et al
    Metabolomics profiling in multi-ancestral individuals with type 2 diabetes in Singapore identified metabolites associated with renal function decline.
    Diabetologia. 2024 Dec 2. doi: 10.1007/s00125-024-06324.
    PubMed     Abstract available


  25. ZEMSKI BERRY KA, Garfield A, Jambal P, Zarini S, et al
    Oxidised phosphatidylcholine induces sarcolemmal ceramide accumulation and insulin resistance in skeletal muscle.
    Diabetologia. 2024;67:2819-2832.
    PubMed     Abstract available


  26. WAT LW, Svensson KJ
    Novel secreted regulators of glucose and lipid metabolism in the development of metabolic diseases.
    Diabetologia. 2024;67:2626-2636.
    PubMed     Abstract available


    November 2024
  27. TRICO D, Sacchetta L, Rebelos E, Cimbalo N, et al
    Postprandial hypoglycaemia after gastric bypass in type 2 diabetes: pathophysiological mechanisms and clinical implications.
    Diabetologia. 2024 Nov 29. doi: 10.1007/s00125-024-06312.
    PubMed     Abstract available


  28. GALDERISI A, Carr ALJ, Martino M, Taylor P, et al
    Correction: Quantifying beta cell function in the preclinical stages of type 1 diabetes.
    Diabetologia. 2024 Nov 27. doi: 10.1007/s00125-024-06335.
    PubMed    


  29. HANICK CJ, Peterson CM, Davis BC, Sabate J, et al
    Correction: A whole-food, plant-based intensive lifestyle intervention improves glycaemic control and reduces medications in individuals with type 2 diabetes: a randomised controlled trial.
    Diabetologia. 2024 Nov 25. doi: 10.1007/s00125-024-06332.
    PubMed    


  30. O CK, Fan B, Tsoi STF, Tam CHT, et al
    A polygenic risk score derived from common variants of monogenic diabetes genes is associated with young-onset type 2 diabetes and cardiovascular-kidney complications.
    Diabetologia. 2024 Nov 23. doi: 10.1007/s00125-024-06320.
    PubMed     Abstract available


  31. GALDERISI A, Sims EK, Evans-Molina C, Petrelli A, et al
    Trajectory of beta cell function and insulin clearance in stage 2 type 1 diabetes: natural history and response to teplizumab.
    Diabetologia. 2024 Nov 19. doi: 10.1007/s00125-024-06323.
    PubMed     Abstract available


  32. LAESSER CI, Piazza C, Schorno N, Nick F, et al
    Simplified meal announcement study (SMASH) using hybrid closed-loop insulin delivery in youth and young adults with type 1 diabetes: a randomised controlled two-centre crossover trial.
    Diabetologia. 2024 Nov 19. doi: 10.1007/s00125-024-06319.
    PubMed     Abstract available


  33. YU G, Tam CHT, Lim CKP, Shi M, et al
    Type 2 diabetes pathway-specific polygenic risk scores elucidate heterogeneity in clinical presentation, disease progression and diabetic complications in 18,217 Chinese individuals with type 2 diabetes.
    Diabetologia. 2024 Nov 12. doi: 10.1007/s00125-024-06309.
    PubMed     Abstract available


  34. ROONEY MR, Wallace AS, Echouffo Tcheugui JB, Fang M, et al
    Prediabetes is associated with elevated risk of clinical outcomes even without progression to diabetes.
    Diabetologia. 2024 Nov 12. doi: 10.1007/s00125-024-06315.
    PubMed     Abstract available


  35. PHILLIPS NE, Mareschal J, Biancolin AD, Sinturel F, et al
    The metabolic and circadian signatures of gestational diabetes in the postpartum period characterised using multiple wearable devices.
    Diabetologia. 2024 Nov 12. doi: 10.1007/s00125-024-06318.
    PubMed     Abstract available


  36. WANG E, Patorno E, Khosrow-Khavar F, Crystal S, et al
    Racial and ethnic disparities in the uptake of SGLT2is and GLP-1RAs among Medicare beneficiaries with type 2 diabetes and heart failure, atherosclerotic cardiovascular disease and chronic kidney disease, 2013-2019.
    Diabetologia. 2024 Nov 8. doi: 10.1007/s00125-024-06321.
    PubMed     Abstract available


  37. AMR RA, Al-Smadi AM, Akasheh RT
    Diabetes knowledge and behaviour: a cross-sectional study of Jordanian adults.
    Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06304.
    PubMed     Abstract available


  38. ELEFTHERIADOU A, Riley D, Zhao SS, Austin P, et al
    Addressing methodological considerations in the assessment of the effect of SGLT2 inhibitors and GLP-1 receptor agonists on diabetic eye complications. Reply to Tsai Y-H, Hemphill NO, Kurth T.
    Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06314.
    PubMed    



  39. Correction: 60(th) EASD Annual Meeting of the European Association for the Study of Diabetes, Madrid, Spain, 9-13 September 2024. 'Average glucose and HbA(1c) display a nonlinear and variable relationship: implications for clinical practice'.
    Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06294.
    PubMed    


  40. LAN NSR, Hiew J, Ferreira I, Ritter JC, et al
    Increased risk of major adverse cardiovascular events in patients with deep and infected diabetes-related foot ulcers.
    Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06316.
    PubMed     Abstract available


  41. GOTTMANN P, Speckmann T, Stadion M, Chawla P, et al
    Transcriptomic heterogeneity of non-beta islet cells is associated with type 2 diabetes development in mouse models.
    Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06301.
    PubMed     Abstract available


  42. RAO C, Cater DT, Roy S, Xu J, et al
    Beta cell extracellular vesicle PD-L1 as a novel regulator of CD8(+) T cell activity and biomarker during the evolution of type 1 diabetes.
    Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06313.
    PubMed     Abstract available


  43. MA RCW, Tam CHT, Hou Y, Lau ESH, et al
    NT-proBNP improves prediction of cardiorenal complications in type 2 diabetes: the Hong Kong Diabetes Biobank.
    Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06299.
    PubMed     Abstract available


  44. GESUITA R, Eckert AJ, Besancon S, Crimmins NA, et al
    Frequency and clinical characteristics of children and young people with type 2 diabetes at diagnosis from five world regions between 2012 and 2021: data from the SWEET Registry.
    Diabetologia. 2024 Nov 6. doi: 10.1007/s00125-024-06283.
    PubMed     Abstract available


  45. MEIER DT, de Paula Souza J, Donath MY
    Targeting the NLRP3 inflammasome-IL-1beta pathway in type 2 diabetes and obesity.
    Diabetologia. 2024 Nov 4. doi: 10.1007/s00125-024-06306.
    PubMed     Abstract available


  46. GARDEN GL, Fan KS, Paterson M, Shojaee-Moradie F, et al
    Effects of atmospheric pressure change during flight on insulin pump delivery and glycaemic control of pilots with insulin-treated diabetes: an in vitro simulation and a retrospective observational real-world study.
    Diabetologia. 2024 Nov 4. doi: 10.1007/s00125-024-06295.
    PubMed     Abstract available


  47. GLINTBORG D, Christensen LL, Andersen MS
    Transgender healthcare: metabolic outcomes and cardiovascular risk.
    Diabetologia. 2024;67:2393-2403.
    PubMed     Abstract available



  48. EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary.
    Diabetologia. 2024;67:2375-2392.
    PubMed     Abstract available


    October 2024
  49. HOSTRUP PE, Schmidt T, Hellsten SB, Gerwig RH, et al
    Effect of fenofibrate on residual beta cell function in adults and adolescents with newly diagnosed type 1 diabetes: a randomised clinical trial.
    Diabetologia. 2024 Oct 30. doi: 10.1007/s00125-024-06290.
    PubMed     Abstract available


  50. TSAI YH, OjiNjideka Hemphill N, Kurth T
    Addressing methodological considerations in the assessment of the effect of SGLT2 inhibitors and GLP-1 receptor agonists on risk of diabetic eye complications.
    Diabetologia. 2024 Oct 30. doi: 10.1007/s00125-024-06300.
    PubMed    


  51. VOETS PJGM
    A modified total body water deficit formula for use in diabetes care.
    Diabetologia. 2024 Oct 29. doi: 10.1007/s00125-024-06311.
    PubMed    


  52. HANNA SJ, Bonami RH, Corrie B, Westley M, et al
    The Type 1 Diabetes T Cell Receptor and B Cell Receptor Repository in the AIRR Data Commons: a practical guide for access, use and contributions through the Type 1 Diabetes AIRR Consortium.
    Diabetologia. 2024 Oct 29. doi: 10.1007/s00125-024-06298.
    PubMed     Abstract available


  53. SANTOSO C, Wei Y, Ahlqvist E, Tuomi T, et al
    Autoimmune diseases and the risk and prognosis of latent autoimmune diabetes in adults.
    Diabetologia. 2024 Oct 28. doi: 10.1007/s00125-024-06303.
    PubMed     Abstract available


  54. EDSTORP J, Rossides M, Ahlqvist E, Alfredsson L, et al
    Exposure to antibiotics and risk of latent autoimmune diabetes in adults and type 2 diabetes: results from a Swedish case-control study (ESTRID) and the Norwegian HUNT study.
    Diabetologia. 2024 Oct 28. doi: 10.1007/s00125-024-06302.
    PubMed     Abstract available


  55. NATHANSON D, Eeg-Olofsson K, Spelman T, Bulow E, et al
    Intermittently scanned continuous glucose monitoring compared with blood glucose monitoring is associated with lower HbA(1c) and a reduced risk of hospitalisation for diabetes-related complications in adults with type 2 diabetes on insulin therapies.
    Diabetologia. 2024 Oct 26. doi: 10.1007/s00125-024-06289.
    PubMed     Abstract available


  56. MALLONE R
    Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody?positive pre?stage 3 type 1 diabetes.
    Diabetologia. 2024 Oct 24. doi: 10.1007/s00125-024-06296.
    PubMed    


  57. CHILUNGA FP, Mkoma GF
    GLP-1 receptor agonists in lean diabetes in racial and ethnic minority groups: closing the treatment gap.
    Diabetologia. 2024 Oct 21. doi: 10.1007/s00125-024-06297.
    PubMed    


  58. APAOLAZA PS, Chen YC, Grewal K, Lurz Y, et al
    Quantitative analysis of islet prohormone convertase 1/3 expression in human pancreas donors with diabetes.
    Diabetologia. 2024 Oct 15. doi: 10.1007/s00125-024-06275.
    PubMed     Abstract available


  59. CERIELLO A, Prattichizzo F, Berra C
    Is glycaemic control still central in the hierarchy of priorities in type 2 diabetes management? The way forward is to combine glucose control and the prevention of cardiorenal complications.
    Diabetologia. 2024 Oct 4. doi: 10.1007/s00125-024-06284.
    PubMed    


  60. COLE A, Weight N, Mishra S, Grapsa J, et al
    Addressing disparities in the long-term mortality risk in individuals with non-ST segment myocardial infarction (NSTEMI) by diabetes mellitus status: a nationwide cohort study.
    Diabetologia. 2024 Oct 3. doi: 10.1007/s00125-024-06281.
    PubMed     Abstract available


  61. ZHAO LP, Papadopoulos GK, Skyler JS, Pugliese A, et al
    Progression to type 1 diabetes in the DPT-1 and TN07 clinical trials is critically associated with specific residues in HLA-DQA1-B1 heterodimers.
    Diabetologia. 2024 Oct 1. doi: 10.1007/s00125-024-06274.
    PubMed     Abstract available


  62. OKURA T, Ito Y, Anno M, Endo S, et al
    Postprandial fatty acid-binding protein 4 is associated with muscle insulin resistance.
    Diabetologia. 2024;67:2304-2315.
    PubMed     Abstract available


  63. YAMAGUCHI M, Nakao S, Arima M, Little K, et al
    Heterotypic macrophages/microglia differentially contribute to retinal ischaemia and neovascularisation.
    Diabetologia. 2024;67:2329-2345.
    PubMed     Abstract available


  64. WU Y, Yang M, Wu SB, Luo PQ, et al
    Zinc finger BED-type containing 3 promotes hepatic steatosis by interacting with polypyrimidine tract-binding protein 1.
    Diabetologia. 2024;67:2346-2366.
    PubMed     Abstract available


  65. MELLOR J, Kuznetsov D, Heller S, Gall MA, et al
    Estimating risk of consequences following hypoglycaemia exposure using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials.
    Diabetologia. 2024;67:2210-2224.
    PubMed     Abstract available


  66. GRENKO CM, Taylor HJ, Bonnycastle LL, Xue D, et al
    Single-cell transcriptomic profiling of human pancreatic islets reveals genes responsive to glucose exposure over 24 h.
    Diabetologia. 2024;67:2246-2259.
    PubMed     Abstract available


    September 2024
  67. LIU S, Zhu J, Zhong H, Wu C, et al
    Identification of proteins associated with type 2 diabetes risk in diverse racial and ethnic populations.
    Diabetologia. 2024 Sep 30. doi: 10.1007/s00125-024-06277.
    PubMed     Abstract available


  68. SHARMA S, Dong Q, Haid M, Adam J, et al
    Role of human plasma metabolites in prediabetes and type 2 diabetes from the IMI-DIRECT study.
    Diabetologia. 2024 Sep 30. doi: 10.1007/s00125-024-06282.
    PubMed     Abstract available


  69. HOLMAN N, Yelland AC, Young B, Valabhji J, et al
    Mortality rates in people presenting with a new diabetes-related foot ulcer: a cohort study with implications for management.
    Diabetologia. 2024 Sep 27. doi: 10.1007/s00125-024-06262.
    PubMed     Abstract available


  70. HANICK CJ, Peterson CM, Davis BC, Sabate J, et al
    A whole-food, plant-based intensive lifestyle intervention improves glycaemic control and reduces medications in individuals with type 2 diabetes: a randomised controlled trial.
    Diabetologia. 2024 Sep 21. doi: 10.1007/s00125-024-06272.
    PubMed     Abstract available


  71. ELBARBARY NS, Ismail EA, El-Hamamsy MH, Ibrahim MZ, et al
    The DPP-4 inhibitor sitagliptin improves glycaemic control and early-stage diabetic nephropathy in adolescents with type 1 diabetes using the MiniMed 780G advanced hybrid closed-loop system: a randomised controlled trial.
    Diabetologia. 2024 Sep 14. doi: 10.1007/s00125-024-06265.
    PubMed     Abstract available


  72. TSATSARIS G, Rajamand Ekberg N, Fall T, Catrina SB, et al
    Risk factors for Charcot foot development in individuals with diabetes mellitus.
    Diabetologia. 2024 Sep 13. doi: 10.1007/s00125-024-06271.
    PubMed     Abstract available


  73. HEIKKILA TE, Kaiser EK, Lin J, Gill D, et al
    Genetic evidence for efficacy of targeting IL-2, IL-6 and TYK2 signalling in the prevention of type 1 diabetes: a Mendelian randomisation study.
    Diabetologia. 2024 Sep 13. doi: 10.1007/s00125-024-06267.
    PubMed     Abstract available


  74. LAVENS A, De Block C, Oriot P, Crenier L, et al
    Metabolic health in people living with type 1 diabetes in Belgium: a repeated cross-sectional study.
    Diabetologia. 2024 Sep 13. doi: 10.1007/s00125-024-06273.
    PubMed     Abstract available



  75. 60(th) EASD Annual Meeting of the European Association for the Study of Diabetes : Madrid, Spain, 9 - 13 September 2024.
    Diabetologia. 2024 Sep 12. doi: 10.1007/s00125-024-06226.
    PubMed    


  76. GALINDO RJ, Soliman D, Chernavvsky D, Rhee CM, et al
    Correction: Diabetes technology in people with diabetes and advanced chronic kidney disease.
    Diabetologia. 2024 Sep 10. doi: 10.1007/s00125-024-06278.
    PubMed    


  77. LENZEN S
    Comment on the role of interferons in the pathology of beta cell destruction in type 1 diabetes.
    Diabetologia. 2024 Sep 7. doi: 10.1007/s00125-024-06264.
    PubMed    


  78. SORIA-CONTRERAS DC, Wang S, Liu J, Lawn RB, et al
    Lifetime history of gestational diabetes and cognitive function in parous women in midlife.
    Diabetologia. 2024 Sep 6. doi: 10.1007/s00125-024-06270.
    PubMed     Abstract available


  79. WACHOWSKI NA, Pippin JA, Boehm K, Lu S, et al
    Implicating type 2 diabetes effector genes in relevant metabolic cellular models using promoter-focused Capture-C.
    Diabetologia. 2024 Sep 6. doi: 10.1007/s00125-024-06261.
    PubMed     Abstract available


  80. EIZIRIK DL, Zimath PL, Yi X, Roca Rivada A, et al
    Comment on the role of interferons in the pathology of beta cell destruction in type 1 diabetes. Reply to Lenzen S [letter].
    Diabetologia. 2024 Sep 5. doi: 10.1007/s00125-024-06269.
    PubMed    


  81. PHILLIP M, Achenbach P, Addala A, Albanese-O'Neill A, et al
    Correction to: Consensus guidance for monitoring individuals with islet autoantibody?positive pre?stage 3 type 1 diabetes.
    Diabetologia. 2024 Sep 4. doi: 10.1007/s00125-024-06266.
    PubMed    


  82. THOMSON RL, Brown JD, Oakey H, Palmer K, et al
    Dietary patterns during pregnancy and maternal and birth outcomes in women with type 1 diabetes: the Environmental Determinants of Islet Autoimmunity (ENDIA) study.
    Diabetologia. 2024 Sep 2. doi: 10.1007/s00125-024-06259.
    PubMed     Abstract available


  83. ESSER N, Hogan MF, Templin AT, Akter R, et al
    The islet tissue plasminogen activator/plasmin system is upregulated with human islet amyloid polypeptide aggregation and protects beta cells from aggregation-induced toxicity.
    Diabetologia. 2024;67:1897-1911.
    PubMed     Abstract available


  84. LITHOVIUS V, Lahdenpohja S, Ibrahim H, Saarimaki-Vire J, et al
    Non-invasive quantification of stem cell-derived islet graft size and composition.
    Diabetologia. 2024;67:1912-1929.
    PubMed     Abstract available


  85. WREVEN E, Ruiz de Adana MS, Hardiville S, Gmyr V, et al
    Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans.
    Diabetologia. 2024;67:1877-1896.
    PubMed     Abstract available


  86. MAKINEN S, Sree S, Ala-Nisula T, Kultalahti H, et al
    Activation of the hypoxia-inducible factor pathway by roxadustat improves glucose metabolism in human primary myotubes from men.
    Diabetologia. 2024;67:1943-1954.
    PubMed     Abstract available


    August 2024
  87. DUNNE F, Newman C, Alvarez-Iglesias A, O'Shea P, et al
    Metformin and small for gestational age babies: findings of a randomised placebo-controlled clinical trial of metformin in gestational diabetes (EMERGE).
    Diabetologia. 2024 Aug 31. doi: 10.1007/s00125-024-06252.
    PubMed     Abstract available


  88. MALLIK R, Kar P, Mulder H, Krook A, et al
    The future is here: an overview of technology in diabetes.
    Diabetologia. 2024 Aug 30. doi: 10.1007/s00125-024-06235.
    PubMed    


  89. SCIBILIA R, Breslin-Brooker N, Bright C, Dzikiti T, et al
    Global experiences and personal narratives on diabetes technology and access.
    Diabetologia. 2024 Aug 30. doi: 10.1007/s00125-024-06230.
    PubMed    


  90. LIN DS, Lee JK, Huang KC, Lin TT, et al
    Effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes in people with diabetes and advanced chronic kidney disease.
    Diabetologia. 2024 Aug 29. doi: 10.1007/s00125-024-06257.
    PubMed     Abstract available


  91. FADINI GP, Longato E, Morieri ML, Bonora E, et al
    Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care.
    Diabetologia. 2024 Aug 23. doi: 10.1007/s00125-024-06251.
    PubMed     Abstract available


  92. TANABE H, Sato M, Miyake A, Shimajiri Y, et al
    Machine learning-based reproducible prediction of type 2 diabetes subtypes.
    Diabetologia. 2024 Aug 21. doi: 10.1007/s00125-024-06248.
    PubMed     Abstract available


  93. KHUNTI K, Zaccardi F, Amod A, Aroda VR, et al
    Glycaemic control is still central in the hierarchy of priorities in type 2 diabetes management.
    Diabetologia. 2024 Aug 19. doi: 10.1007/s00125-024-06254.
    PubMed     Abstract available


  94. LEHNER CT, Schauberger G, Klug SJ
    Reduced type 2 diabetes incidence reflecting end of post?World War II calorie restrictions in Germany. Reply to Nilsson PM, Vaag A [letter].
    Diabetologia. 2024 Aug 17. doi: 10.1007/s00125-024-06255.
    PubMed    


  95. PERKINS BA, Turner LV, Riddell MC
    Applying technologies to simplify strategies for exercise in type 1 diabetes.
    Diabetologia. 2024 Aug 15. doi: 10.1007/s00125-024-06229.
    PubMed     Abstract available


  96. NILSSON PM, Vaag A
    Reduced type 2 diabetes incidence reflecting end of post-World War II calorie restrictions in Germany.
    Diabetologia. 2024 Aug 15. doi: 10.1007/s00125-024-06195.
    PubMed    


  97. ADEBEKUN J, Nadig A, Saarah P, Asgari S, et al
    Genetic relations between type 1 diabetes, coronary artery disease and leukocyte counts.
    Diabetologia. 2024 Aug 14. doi: 10.1007/s00125-024-06247.
    PubMed     Abstract available


  98. SMITH K, Taylor GS, Peeters W, Walker M, et al
    Elevations in plasma glucagon are associated with reduced insulin clearance after ingestion of a mixed-macronutrient meal in people with and without type 2 diabetes.
    Diabetologia. 2024 Aug 13. doi: 10.1007/s00125-024-06249.
    PubMed     Abstract available


  99. MALTESE G, McAuley SA, Trawley S, Sinclair AJ, et al
    Ageing well with diabetes: the role of technology.
    Diabetologia. 2024 Aug 13. doi: 10.1007/s00125-024-06240.
    PubMed     Abstract available


  100. ELEFTHERIADOU A, Spallone V, Tahrani AA, Alam U, et al
    Cardiovascular autonomic neuropathy in diabetes: an update with a focus on management.
    Diabetologia. 2024 Aug 9. doi: 10.1007/s00125-024-06242.
    PubMed     Abstract available


  101. GALINDO RJ, Soliman D, Chernasvvky D, Rhee CM, et al
    Diabetes technology in people with diabetes and advanced chronic kidney disease.
    Diabetologia. 2024 Aug 8. doi: 10.1007/s00125-024-06244.
    PubMed     Abstract available


  102. YOU L, Ferrat LA, Oram RA, Parikh HM, et al
    Identification of type 1 diabetes risk phenotypes using an outcome-guided clustering analysis.
    Diabetologia. 2024 Aug 6. doi: 10.1007/s00125-024-06246.
    PubMed     Abstract available


  103. HAUKKA JK, Antikainen AA, Valo E, Syreeni A, et al
    Whole-exome and whole-genome sequencing of 1064 individuals with type 1 diabetes reveals novel genes for diabetic kidney disease.
    Diabetologia. 2024 Aug 6. doi: 10.1007/s00125-024-06241.
    PubMed     Abstract available


  104. HURTADO I, Robles C, Peiro S, Garcia-Sempere A, et al
    Association of glucagon-like peptide-1 receptor agonists with suicidal ideation and self-injury in individuals with diabetes and obesity: a propensity-weighted, population-based cohort study.
    Diabetologia. 2024 Aug 6. doi: 10.1007/s00125-024-06243.
    PubMed     Abstract available


  105. RASHID R, Chaudhry D, Evison F, Sharif A, et al
    Mortality risk for kidney transplant candidates with diabetes: a population cohort study.
    Diabetologia. 2024 Aug 6. doi: 10.1007/s00125-024-06245.
    PubMed     Abstract available



  106. Up Front.
    Diabetologia. 2024;67:1453-1454.
    PubMed    


  107. VISA M, Berggren PO
    Sex-dependent intra-islet structural rearrangements affecting alpha-to-beta cell interactions lead to adaptive enhancements of Ca(2+) dynamics in prediabetic beta cells.
    Diabetologia. 2024;67:1663-1682.
    PubMed     Abstract available


  108. MELLOR J, Kuznetsov D, Heller S, Gall MA, et al
    Risk factors and prediction of hypoglycaemia using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials.
    Diabetologia. 2024;67:1588-1601.
    PubMed     Abstract available


  109. WINTHER-SORENSEN M, Garcia SL, Bartholdy A, Ottenheijm ME, et al
    Determinants of plasma levels of proglucagon and the metabolic impact of glucagon receptor signalling: a UK Biobank study.
    Diabetologia. 2024;67:1602-1615.
    PubMed     Abstract available


    July 2024
  110. MASALIN S, Klavus A, Rono K, Koistinen HA, et al
    Analysis of early-pregnancy metabolome in early- and late-onset gestational diabetes reveals distinct associations with maternal overweight.
    Diabetologia. 2024 Jul 31. doi: 10.1007/s00125-024-06237.
    PubMed     Abstract available


  111. SOHOLM U, Broadley M, Zaremba N, Divilly P, et al
    The impact of hypoglycaemia on daily functioning among adults with diabetes: a prospective observational study using the Hypo-METRICS app.
    Diabetologia. 2024 Jul 30. doi: 10.1007/s00125-024-06233.
    PubMed     Abstract available


  112. EHRMANN D, Hermanns N, Schmitt A, Klinker L, et al
    Perceived glucose levels matter more than CGM-based data in predicting diabetes distress in type 1 or type 2 diabetes: a precision mental health approach using n-of-1 analyses.
    Diabetologia. 2024 Jul 30. doi: 10.1007/s00125-024-06239.
    PubMed     Abstract available


  113. VERNSTROM L, Gullaksen S, Sorensen SS, Ringgaard S, et al
    Effects of semaglutide, empagliflozin and their combination on renal diffusion-weighted MRI and total kidney volume in patients with type 2 diabetes: a post hoc analysis from a 32 week randomised trial.
    Diabetologia. 2024 Jul 30. doi: 10.1007/s00125-024-06228.
    PubMed     Abstract available


  114. LUNDGAARD AT, Westergaard D, Roder T, Burgdorf KS, et al
    Longitudinal metabolite and protein trajectories prior to diabetes mellitus diagnosis in Danish blood donors: a nested case-control study.
    Diabetologia. 2024 Jul 30. doi: 10.1007/s00125-024-06231.
    PubMed     Abstract available


  115. MOLVEAU J, Myette-Cote E, Tagougui S, Taleb N, et al
    Assessing the influence of insulin type (ultra-rapid vs rapid insulin) and exercise timing on postprandial exercise-induced hypoglycaemia risk in individuals with type 1 diabetes: a randomised controlled trial.
    Diabetologia. 2024 Jul 29. doi: 10.1007/s00125-024-06234.
    PubMed     Abstract available


  116. KONDO A, McGrady M, Nallapothula D, Ali H, et al
    Spatial proteomics of human diabetic kidney disease, from health to class III.
    Diabetologia. 2024 Jul 22. doi: 10.1007/s00125-024-06210.
    PubMed     Abstract available


  117. DONOVAN LE, Bell RC, Feig DS, Lemieux P, et al
    Glycaemic patterns during breastfeeding with postpartum use of closed-loop insulin delivery in women with type 1 diabetes.
    Diabetologia. 2024 Jul 19. doi: 10.1007/s00125-024-06227.
    PubMed     Abstract available


  118. DU S, Sullivan VK, Fang M, Appel LJ, et al
    Ultra-processed food consumption and risk of diabetes: results from a population-based prospective cohort.
    Diabetologia. 2024 Jul 13. doi: 10.1007/s00125-024-06221.
    PubMed     Abstract available


  119. SCULLY KJ, Marks BE, Putman MS
    Advances in diabetes technology to improve the lives of people with cystic fibrosis.
    Diabetologia. 2024 Jul 12. doi: 10.1007/s00125-024-06223.
    PubMed     Abstract available


  120. SCHOELWER MJ, DeBoer MD, Breton MD
    Use of diabetes technology in children.
    Diabetologia. 2024 Jul 12. doi: 10.1007/s00125-024-06218.
    PubMed     Abstract available


  121. WANG W, Bain SC, Bian F, Chen R, et al
    Efficacy and safety of oral semaglutide monotherapy vs placebo in a predominantly Chinese population with type 2 diabetes (PIONEER 11): a double-blind, Phase IIIa, randomised trial.
    Diabetologia. 2024 Jul 10. doi: 10.1007/s00125-024-06142.
    PubMed     Abstract available


  122. JI L, Agesen RM, Bain SC, Fu F, et al
    Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial.
    Diabetologia. 2024 Jul 10. doi: 10.1007/s00125-024-06133.
    PubMed     Abstract available


  123. LUNA-MARCO C, Devos D, Cacace J, Fernandez-Reyes M, et al
    Molecular circadian clock disruption in the leukocytes of individuals with type 2 diabetes and overweight, and its relationship with leukocyte-endothelial interactions.
    Diabetologia. 2024 Jul 10. doi: 10.1007/s00125-024-06219.
    PubMed     Abstract available


  124. BROZZI F, Jacovetti C, Cosentino C, Menoud V, et al
    tRNA-derived fragments in T lymphocyte-beta cell crosstalk and in type 1 diabetes pathogenesis in NOD mice.
    Diabetologia. 2024 Jul 5. doi: 10.1007/s00125-024-06207.
    PubMed     Abstract available


  125. DE WIT DF, Fuhri Snethlage CM, Rampanelli E, Maasen K, et al
    Higher fibre and lower carbohydrate intake are associated with favourable CGM metrics in a cross-sectional cohort of 470 individuals with type 1 diabetes.
    Diabetologia. 2024 Jul 5. doi: 10.1007/s00125-024-06213.
    PubMed     Abstract available


  126. MCLEAN A, Maple-Brown L, Murphy HR
    Technology advances in diabetes pregnancy: right technology, right person, right time.
    Diabetologia. 2024 Jul 5. doi: 10.1007/s00125-024-06216.
    PubMed     Abstract available


  127. DONNELLY LA, McCrimmon RJ, Pearson ER
    Trajectories of BMI before and after diagnosis of type 2 diabetes in a real-world population.
    Diabetologia. 2024 Jul 5. doi: 10.1007/s00125-024-06217.
    PubMed     Abstract available


  128. THABIT H, Schofield J
    Technology in the management of diabetes in hospitalised adults.
    Diabetologia. 2024 Jul 2. doi: 10.1007/s00125-024-06206.
    PubMed     Abstract available



  129. Up Front.
    Diabetologia. 2024;67:1163-1164.
    PubMed    


  130. GYLFE E, Tengholm A
    Bo Hellman, 19 June 1930-4 December 2023.
    Diabetologia. 2024;67:1165-1167.
    PubMed    


  131. BRAKENRIDGE CJ, Koster A, de Galan BE, Carver A, et al
    Associations of 24 h time-use compositions of sitting, standing, physical activity and sleeping with optimal cardiometabolic risk and glycaemic control: The Maastricht Study.
    Diabetologia. 2024;67:1356-1367.
    PubMed     Abstract available


  132. HTOO PT, Tesfaye H, Schneeweiss S, Wexler DJ, et al
    Effectiveness and safety of empagliflozin: final results from the EMPRISE study.
    Diabetologia. 2024;67:1328-1342.
    PubMed     Abstract available


    June 2024
  133. LIARAKOS AL, Lim JZM, Leelarathna L, Wilmot EG, et al
    The use of technology in type 2 diabetes and prediabetes: a narrative review.
    Diabetologia. 2024 Jun 29. doi: 10.1007/s00125-024-06203.
    PubMed     Abstract available


  134. HASLAM DE, Liang L, Guo K, Martinez-Lozano M, et al
    Correction: Discovery and validation of plasma, saliva and multi-fluid plasma-saliva metabolomic scores predicting insulin resistance and diabetes progression or regression among Puerto Rican adults.
    Diabetologia. 2024 Jun 28. doi: 10.1007/s00125-024-06199.
    PubMed    


  135. XIAO Q, Full KM, Rutter MK, Lipworth L, et al
    Long-term trajectories of sleep duration are associated with incident diabetes in middle-to-older-aged Black and White Americans.
    Diabetologia. 2024 Jun 27. doi: 10.1007/s00125-024-06202.
    PubMed     Abstract available


  136. KENNEDY B, Wernroth ML, Batra G, Hammar U, et al
    Major cardiovascular events and death in parents of children with type 1 diabetes: a register-based matched cohort study in Sweden.
    Diabetologia. 2024 Jun 26. doi: 10.1007/s00125-024-06200.
    PubMed     Abstract available


  137. FUHRI SNETHLAGE CM, Balvers M, Ferwerda B, Rampanelli E, et al
    Associations between diabetes-related genetic risk scores and residual beta cell function in type 1 diabetes: the GUTDM1 study.
    Diabetologia. 2024 Jun 26. doi: 10.1007/s00125-024-06204.
    PubMed     Abstract available


  138. BYNDLOSS M, Devkota S, Duca F, Niess JH, et al
    The gut microbiota and diabetes: research, translation, and clinical applications - 2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum.
    Diabetologia. 2024 Jun 24. doi: 10.1007/s00125-024-06198.
    PubMed     Abstract available


  139. PHILLIP M, Achenbach P, Addala A, Albanese-O'Neill A, et al
    Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes.
    Diabetologia. 2024 Jun 24. doi: 10.1007/s00125-024-06205.
    PubMed     Abstract available


  140. D'ALESSIO DA, Kahn SE, Mulder H
    The gut microbiota and diabetes: clarity on an emerging topic and introduction to a new partnership and journal feature.
    Diabetologia. 2024 Jun 24. doi: 10.1007/s00125-024-06208.
    PubMed    


  141. UMPIERREZ GE, Davis GM, ElSayed NA, Fadini GP, et al
    Hyperglycaemic crises in adults with diabetes: a consensus report.
    Diabetologia. 2024 Jun 22. doi: 10.1007/s00125-024-06183.
    PubMed     Abstract available


  142. MUTHUKUMAR A, Badawy L, Mangelis A, Vas P, et al
    HbA(1c) variability is independently associated with progression of diabetic kidney disease in an urban multi-ethnic cohort of people with type 1 diabetes.
    Diabetologia. 2024 Jun 20. doi: 10.1007/s00125-024-06197.
    PubMed     Abstract available


  143. GAO L, Ramirez FJ, Cabrera JTO, Varghese MV, et al
    eNAMPT is a novel therapeutic target for mitigation of coronary microvascular disease in type 2 diabetes.
    Diabetologia. 2024 Jun 19. doi: 10.1007/s00125-024-06201.
    PubMed     Abstract available


  144. KOBAYASHI Y, Long J, Johannsen NM, Talamoa R, et al
    Is strength training more effective than aerobic exercise for improving glycaemic control and body composition in people with normal-weight type 2 diabetes? Reply to Pontes?Silva A, Santos?de?Araujo AD, Teixeira BC et al [letter].
    Diabetologia. 2024 Jun 18. doi: 10.1007/s00125-024-06181.
    PubMed    


  145. WU M, Yoon CY, Park J, Kim G, et al
    The role of PCSK9 in glomerular lipid accumulation and renal injury in diabetic kidney disease.
    Diabetologia. 2024 Jun 15. doi: 10.1007/s00125-024-06191.
    PubMed     Abstract available


  146. MCNEILLY AD, Gallagher JR, Evans ML, de Galan BE, et al
    Correction: Chronic hyperglycaemia increases the vulnerability of the hippocampus to oxidative damage induced during post-hypoglycaemic hyperglycaemia in a mouse model of chemically induced type 1 diabetes.
    Diabetologia. 2024 Jun 12. doi: 10.1007/s00125-024-06188.
    PubMed    


  147. GUDEMANN LM, Young KG, Thomas NJM, Hopkins R, et al
    Safety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years: an instrumental variable approach.
    Diabetologia. 2024 Jun 5. doi: 10.1007/s00125-024-06190.
    PubMed     Abstract available


  148. VATANEN T, de Beaufort C, Marcovecchio ML, Overbergh L, et al
    Gut microbiome shifts in people with type 1 diabetes are associated with glycaemic control: an INNODIA study.
    Diabetologia. 2024 Jun 4. doi: 10.1007/s00125-024-06192.
    PubMed     Abstract available


    May 2024
  149. ZHANG J, Zhang R, Liu C, Ge X, et al
    Missense mutation of ISL1 (E283D) is associated with the development of type 2 diabetes.
    Diabetologia. 2024 May 31. doi: 10.1007/s00125-024-06186.
    PubMed     Abstract available


  150. SINGH T, Weiss A, Vehik K, Krischer J, et al
    Caesarean section and risk of type 1 diabetes.
    Diabetologia. 2024 May 31. doi: 10.1007/s00125-024-06176.
    PubMed     Abstract available


  151. JEVON D, Cottle L, Hallahan N, Harwood R, et al
    Capillary contact points determine beta cell polarity, control secretion and are disrupted in the db/db mouse model of diabetes.
    Diabetologia. 2024 May 30. doi: 10.1007/s00125-024-06180.
    PubMed     Abstract available


  152. GROEGLER J, Callebaut A, James EA, Delong T, et al
    The insulin secretory granule is a hotspot for autoantigen formation in type 1 diabetes.
    Diabetologia. 2024 May 29. doi: 10.1007/s00125-024-06164.
    PubMed     Abstract available


  153. SALVATORI B, Wegener S, Kotzaeridi G, Herding A, et al
    Identification and validation of gestational diabetes subgroups by data-driven cluster analysis.
    Diabetologia. 2024 May 27. doi: 10.1007/s00125-024-06184.
    PubMed     Abstract available


  154. DE MEULEMEESTER J, Charleer S, Visser MM, De Block C, et al
    The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study.
    Diabetologia. 2024 May 24. doi: 10.1007/s00125-024-06171.
    PubMed     Abstract available


  155. FAGHERAZZI G, Aguayo GA, Zhang L, Hanaire H, et al
    Heterogeneity of glycaemic phenotypes in type 1 diabetes.
    Diabetologia. 2024 May 23. doi: 10.1007/s00125-024-06179.
    PubMed     Abstract available


  156. JUMPERTZ VON SCHWARTZENBERG R, Vazquez Arreola E, Sandforth A, Hanson RL, et al
    Role of weight loss-induced prediabetes remission in the prevention of type 2 diabetes: time to improve diabetes prevention.
    Diabetologia. 2024 May 23. doi: 10.1007/s00125-024-06178.
    PubMed    


  157. HANSEN AL, Brons C, Engelhard LM, Andersen MK, et al
    Low birthweight in patients with type 2 diabetes is associated with elevated risk of cardiovascular events and mortality.
    Diabetologia. 2024 May 22. doi: 10.1007/s00125-024-06170.
    PubMed     Abstract available


  158. CARLTON J, Powell PA, Broadley M, de Galan BE, et al
    Development of a new health-related quality of life measure for people with diabetes who experience hypoglycaemia: the Hypo-RESOLVE QoL.
    Diabetologia. 2024 May 22. doi: 10.1007/s00125-024-06182.
    PubMed     Abstract available


  159. PONTES-SILVA A, Santos-de-Araujo AD, Teixeira BC, Carteri RB, et al
    Is strength training more effective than aerobic exercise for improving glycaemic control and body composition in people with normal-weight type 2 diabetes?
    Diabetologia. 2024 May 22. doi: 10.1007/s00125-024-06121.
    PubMed    


  160. HASLAM DE, Liang L, Guo K, Martinez-Lozano M, et al
    Discovery and validation of plasma, saliva and multi-fluid plasma-saliva metabolomic scores predicting insulin resistance and diabetes progression or regression among Puerto Rican adults.
    Diabetologia. 2024 May 21. doi: 10.1007/s00125-024-06169.
    PubMed     Abstract available


  161. YUAN S, Leffler D, Lebwohl B, Green PHR, et al
    Coeliac disease and type 2 diabetes risk: a nationwide matched cohort and Mendelian randomisation study.
    Diabetologia. 2024 May 21. doi: 10.1007/s00125-024-06175.
    PubMed     Abstract available


  162. DEL PRATO S, Torbeyns B, Mathieu C
    2024: The year to take European action on diabetes to the next level.
    Diabetologia. 2024 May 18. doi: 10.1007/s00125-024-06166.
    PubMed    


  163. SHEU A, White CP, Center JR
    Bone metabolism in diabetes: a clinician's guide to understanding the bone-glucose interplay.
    Diabetologia. 2024 May 18. doi: 10.1007/s00125-024-06172.
    PubMed     Abstract available


  164. IBRAHIM H, Balboa D, Saarimaki-Vire J, Montaser H, et al
    RFX6 haploinsufficiency predisposes to diabetes through impaired beta cell function.
    Diabetologia. 2024 May 14. doi: 10.1007/s00125-024-06163.
    PubMed     Abstract available


  165. BOUGHTON CK, Hovorka R
    The role of automated insulin delivery technology in diabetes.
    Diabetologia. 2024 May 13. doi: 10.1007/s00125-024-06165.
    PubMed     Abstract available


  166. CORPELEIJN WE, de Waal WJ, Schipper HS, Wiegman A, et al
    Should children with type 1 diabetes really receive statin treatment using the same criteria as for children with familial hypercholesterolaemia? Reply to Sanchez?Hernandez and Wagner [letter].
    Diabetologia. 2024 May 13. doi: 10.1007/s00125-024-06174.
    PubMed    


  167. GULLAKSEN S, Vernstrom L, Sorensen SS, Ringgaard S, et al
    Correction: Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial.
    Diabetologia. 2024 May 13. doi: 10.1007/s00125-024-06167.
    PubMed    


  168. VAN DER SCHUEREN B, Vrijlandt P, Thomson A, Janssen H, et al
    New guideline of the European Medicines Agency (EMA) on the clinical investigation of medicinal products in the treatment and prevention of diabetes mellitus.
    Diabetologia. 2024 May 4. doi: 10.1007/s00125-024-06162.
    PubMed    


  169. RAUSCHER FG, Elze T, Francke M, Martinez-Perez ME, et al
    Glucose tolerance and insulin resistance/sensitivity associate with retinal layer characteristics: the LIFE-Adult-Study.
    Diabetologia. 2024;67:928-939.
    PubMed     Abstract available


  170. RUISSEN MM, Steyerberg EW, Huisman SD, de Graaf AA, et al
    Critical comments regarding the assessment of quality of life and the clinical impact of the POWER2DM intervention. Reply to Pouwer F, Deschenes SS [letter].
    Diabetologia. 2024;67:956-957.
    PubMed    


  171. POUWER F, Deschenes S
    Critical comments regarding the assessment of quality of life and the clinical impact of the POWER2DM intervention.
    Diabetologia. 2024;67:954-955.
    PubMed    


  172. IDEVALL-HAGREN O, Incedal Nilsson C, Sanchez G
    Keeping pace: the primary cilium as the conducting baton of the islet.
    Diabetologia. 2024;67:773-782.
    PubMed     Abstract available


    April 2024
  173. KOBAYASHI Y, Long J, Dan S, Johannsen NM, et al
    Correction to: Strength training is more effective than aerobic exercise for improving glycaemic control and body composition in people with normal-weight type 2 diabetes: a randomised controlled trial.
    Diabetologia. 2024 Apr 30. doi: 10.1007/s00125-024-06135.
    PubMed    


  174. TREVISAN R, Conti M, Ciardullo S
    Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes.
    Diabetologia. 2024 Apr 29. doi: 10.1007/s00125-024-06158.
    PubMed     Abstract available


  175. CHEN J, Feng Q, Qiao Y, Pan S, et al
    ACSF2 and lysine lactylation contribute to renal tubule injury in diabetes.
    Diabetologia. 2024 Apr 27. doi: 10.1007/s00125-024-06156.
    PubMed     Abstract available


  176. STERNER ISAKSSON S, Imberg H, Hirsch IB, Schwarcz E, et al
    Discordance between mean glucose and time in range in relation to HbA(1c) in individuals with type 1 diabetes: results from the GOLD and SILVER trials.
    Diabetologia. 2024 Apr 26. doi: 10.1007/s00125-024-06151.
    PubMed     Abstract available


  177. TAYLOR GS, Smith K, Scragg J, McDonald TJ, et al
    The metabolome as a diagnostic for maximal aerobic capacity during exercise in type 1 diabetes.
    Diabetologia. 2024 Apr 25. doi: 10.1007/s00125-024-06153.
    PubMed     Abstract available


  178. DENICOLO S, Reinstadler V, Keller F, Thoni S, et al
    Non-adherence to cardiometabolic medication as assessed by LC-MS/MS in urine and its association with kidney and cardiovascular outcomes in type 2 diabetes mellitus.
    Diabetologia. 2024 Apr 22. doi: 10.1007/s00125-024-06149.
    PubMed     Abstract available


  179. KIM JY, Jin SM, Sim KH, Kim BY, et al
    Continuous glucose monitoring with structured education in adults with type 2 diabetes managed by multiple daily insulin injections: a multicentre randomised controlled trial.
    Diabetologia. 2024 Apr 19. doi: 10.1007/s00125-024-06152.
    PubMed     Abstract available


  180. KIM JY, Jin SM, Kang ES, Kwak SH, et al
    Comparison between a tubeless, on-body automated insulin delivery system and a tubeless, on-body sensor-augmented pump in type 1 diabetes: a multicentre randomised controlled trial.
    Diabetologia. 2024 Apr 18. doi: 10.1007/s00125-024-06155.
    PubMed     Abstract available


  181. LI X, Donnelly LA, Slieker RC, Beulens JWJ, et al
    Trajectories of clinical characteristics, complications and treatment choices in data-driven subgroups of type 2 diabetes.
    Diabetologia. 2024 Apr 16. doi: 10.1007/s00125-024-06147.
    PubMed     Abstract available


  182. SACCO S, Foschi M, Ornello R, De Santis F, et al
    Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.
    Diabetologia. 2024 Apr 16. doi: 10.1007/s00125-024-06146.
    PubMed     Abstract available


  183. KARAGIANNIS T, Malandris K, Avgerinos I, Stamati A, et al
    Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials.
    Diabetologia. 2024 Apr 13. doi: 10.1007/s00125-024-06144.
    PubMed     Abstract available


  184. METSALA J, Risnes K, Persson M, Veijola R, et al
    Gestational age at birth and type 1 diabetes in childhood and young adulthood: a nationwide register study in Finland, Norway and Sweden.
    Diabetologia. 2024 Apr 13. doi: 10.1007/s00125-024-06139.
    PubMed     Abstract available


  185. VALABHJI J, Holman N, Collins N, Young RJ, et al
    Can the introduction of a 12-lead ECG help reduce mortality in those presenting with foot ulceration to multidisciplinary diabetic foot clinics? An observational evaluation of a real-world implementation pilot in England.
    Diabetologia. 2024 Apr 8. doi: 10.1007/s00125-024-06134.
    PubMed     Abstract available


  186. ELEFTHERIADOU A, Riley D, Zhao SS, Austin P, et al
    Risk of diabetic retinopathy and diabetic macular oedema with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database.
    Diabetologia. 2024 Apr 8. doi: 10.1007/s00125-024-06132.
    PubMed     Abstract available


  187. SIERRA-SILVESTRE E, Andrade RJ, Colorado LH, Edwards K, et al
    Correction to: Occurrence of corneal sub-epithelial microneuromas and axonal swelling in people with diabetes with and without (painful) diabetic neuropathy.
    Diabetologia. 2024 Apr 5. doi: 10.1007/s00125-024-06138.
    PubMed    


  188. LIU B, Xie D, Huang X, Jin S, et al
    Skeletal muscle TET3 promotes insulin resistance through destabilisation of PGC-1alpha.
    Diabetologia. 2024;67:724-737.
    PubMed     Abstract available


  189. XIE C, Iroga P, Bound MJ, Grivell J, et al
    Impact of the timing of metformin administration on glycaemic and glucagon-like peptide-1 responses to intraduodenal glucose infusion in type 2 diabetes: a double-blind, randomised, placebo-controlled, crossover study.
    Diabetologia. 2024 Apr 1. doi: 10.1007/s00125-024-06131.
    PubMed     Abstract available


    March 2024
  190. KORNUM DS, Bertoli D, Kufaishi H, Wegeberg AM, et al
    Transcutaneous vagal nerve stimulation for treating gastrointestinal symptoms in individuals with diabetes: a randomised, double-blind, sham-controlled, multicentre trial.
    Diabetologia. 2024 Mar 28. doi: 10.1007/s00125-024-06129.
    PubMed     Abstract available


  191. VAN DEN BURG EL, Schoonakker MP, van Peet PG, van den Akker-van Marle EM, et al
    Integration of a fasting-mimicking diet programme in primary care for type 2 diabetes reduces the need for medication and improves glycaemic control: a 12-month randomised controlled trial.
    Diabetologia. 2024 Mar 28. doi: 10.1007/s00125-024-06137.
    PubMed     Abstract available


  192. MARCOVECCHIO ML, Hendriks AEJ, Delfin C, Battelino T, et al
    The INNODIA Type 1 Diabetes Natural History Study: a European cohort of newly diagnosed children, adolescents and adults.
    Diabetologia. 2024 Mar 22. doi: 10.1007/s00125-024-06124.
    PubMed     Abstract available


  193. TURNER LV, Marak MC, Gal RL, Calhoun P, et al
    Associations between daily step count classifications and continuous glucose monitoring metrics in adults with type 1 diabetes: analysis of the Type 1 Diabetes Exercise Initiative (T1DEXI) cohort.
    Diabetologia. 2024 Mar 19. doi: 10.1007/s00125-024-06127.
    PubMed     Abstract available


  194. LUND-BLIX NA, Bjerregaard AA, Tapia G, Stordal K, et al
    No association between long-chain n-3 fatty acid intake during pregnancy and risk of type 1 diabetes in offspring in two large Scandinavian pregnancy cohorts.
    Diabetologia. 2024 Mar 19. doi: 10.1007/s00125-024-06125.
    PubMed     Abstract available


  195. GUSTAFSON D, DiStefano PV, Wang XF, Wu R, et al
    Circulating small extracellular vesicles mediate vascular hyperpermeability in diabetes.
    Diabetologia. 2024 Mar 15. doi: 10.1007/s00125-024-06120.
    PubMed     Abstract available


  196. MONTEYNE AJ, Falkenhain K, Whelehan G, Neudorf H, et al
    A ketone monoester drink reduces postprandial blood glucose concentrations in adults with type 2 diabetes: a randomised controlled trial.
    Diabetologia. 2024 Mar 14. doi: 10.1007/s00125-024-06122.
    PubMed     Abstract available


  197. REGNAULT N, Lebreton E, Tang L, Fosse-Edorh S, et al
    Maternal and neonatal outcomes according to the timing of diagnosis of hyperglycaemia in pregnancy: a nationwide cross-sectional study of 695,912 deliveries in France in 2018.
    Diabetologia. 2024;67:516-527.
    PubMed     Abstract available


  198. GRILL V, Sorgjerd E, Hals I, Carlsson S, et al
    Comments on the notion of false positivity in measurements of autoantibodies.
    Diabetologia. 2024;67:567-568.
    PubMed    


  199. GANDASI NR, Gao R, Kothegala L, Pearce A, et al
    GLP-1 metabolite GLP-1(9-36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion.
    Diabetologia. 2024;67:528-546.
    PubMed     Abstract available


  200. HEIANZA Y, Zhou T, Wang X, Furtado JD, et al
    MTNR1B genotype and effects of carbohydrate quantity and dietary glycaemic index on glycaemic response to an oral glucose load: the OmniCarb trial.
    Diabetologia. 2024;67:506-515.
    PubMed     Abstract available


  201. SHE R, Suvitaival T, Andersen HU, Hommel E, et al
    Metabolic effect of adrenaline infusion in people with type 1 diabetes and healthy individuals.
    Diabetologia. 2024 Mar 1. doi: 10.1007/s00125-024-06116.
    PubMed     Abstract available


    February 2024
  202. SU M, Hou Y, Cai S, Li W, et al
    Elevated ITGA1 levels in type 2 diabetes: implications for cardiac function impairment.
    Diabetologia. 2024 Feb 27. doi: 10.1007/s00125-024-06109.
    PubMed     Abstract available


  203. JIN Q, Lau ESH, Luk AO, Tam CHT, et al
    Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes Biobank.
    Diabetologia. 2024 Feb 27. doi: 10.1007/s00125-024-06108.
    PubMed     Abstract available


  204. REUTRAKUL S, Park JC, McAnany JJ, Chau FY, et al
    Dysregulated 24 h melatonin secretion associated with intrinsically photosensitive retinal ganglion cell function in diabetic retinopathy: a cross-sectional study.
    Diabetologia. 2024 Feb 27. doi: 10.1007/s00125-024-06118.
    PubMed     Abstract available


  205. TER BRAAKE JG, Fleetwood KJ, Vos RC, Blackbourn L, et al
    Cardiovascular risk management among individuals with type 2 diabetes and severe mental illness: a cohort study.
    Diabetologia. 2024 Feb 26. doi: 10.1007/s00125-024-06111.
    PubMed     Abstract available


  206. COOMANS DE BRACHENE A, Alvelos MI, Szymczak F, Zimath PL, et al
    Interferons are key cytokines acting on pancreatic islets in type 1 diabetes.
    Diabetologia. 2024 Feb 26. doi: 10.1007/s00125-024-06106.
    PubMed     Abstract available


  207. LEHNER CT, Eberl M, Donnachie E, Tanaka LF, et al
    Incidence trend of type 2 diabetes from 2012 to 2021 in Germany: an analysis of health claims data of 11 million statutorily insured people.
    Diabetologia. 2024 Feb 26. doi: 10.1007/s00125-024-06113.
    PubMed     Abstract available


  208. SANCHEZ-HERNANDEZ RM, Wagner AM
    Should children with type 1 diabetes really receive statin treatment using the same criteria as for children with familial hypercholesterolaemia?
    Diabetologia. 2024 Feb 26. doi: 10.1007/s00125-024-06115.
    PubMed    


  209. BASSET-SAGARMINAGA J, van de Weijer T, Iozzo P, Schrauwen P, et al
    Correction to: Advances and challenges in measuring hepatic glucose uptake with FDG PET: implications for diabetes research.
    Diabetologia. 2024 Feb 23. doi: 10.1007/s00125-024-06112.
    PubMed    


  210. CARDOSO P, Young KG, Nair ATN, Hopkins R, et al
    Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes.
    Diabetologia. 2024 Feb 22. doi: 10.1007/s00125-024-06099.
    PubMed     Abstract available


  211. CELIND J, Bygdell M, Bramsved R, Martikainen J, et al
    Low birthweight and overweight during childhood and young adulthood and the risk of type 2 diabetes in men: a population-based cohort study.
    Diabetologia. 2024 Feb 22. doi: 10.1007/s00125-024-06101.
    PubMed     Abstract available


  212. BELIARD S, Mourre F, Valero R
    Hyperlipidaemia in diabetes: are there particular considerations for next-generation therapies?
    Diabetologia. 2024 Feb 20. doi: 10.1007/s00125-024-06100.
    PubMed     Abstract available


  213. HOLT RIG, Cockram CS, Ma RCW, Luk AOY, et al
    Diabetes and infection: review of the epidemiology, mechanisms and principles of treatment.
    Diabetologia. 2024 Feb 20. doi: 10.1007/s00125-024-06102.
    PubMed     Abstract available


  214. SLIEKER RC, Munch M, Donnelly LA, Bouland GA, et al
    An omics-based machine learning approach to predict diabetes progression: a RHAPSODY study.
    Diabetologia. 2024 Feb 19. doi: 10.1007/s00125-024-06105.
    PubMed     Abstract available


  215. ZHEN J, Gu Y, Wang P, Wang W, et al
    Genome-wide association and Mendelian randomisation analysis among 30,699 Chinese pregnant women identifies novel genetic and molecular risk factors for gestational diabetes and glycaemic traits.
    Diabetologia. 2024 Feb 19. doi: 10.1007/s00125-023-06065.
    PubMed     Abstract available


  216. HYOTY H, Kaariainen S, Laiho JE, Comer GM, et al
    Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial.
    Diabetologia. 2024 Feb 19. doi: 10.1007/s00125-024-06092.
    PubMed     Abstract available


  217. LEE K, Kuang A, Bain JR, Hayes MG, et al
    Metabolomic and genetic architecture of gestational diabetes subtypes.
    Diabetologia. 2024 Feb 17. doi: 10.1007/s00125-024-06110.
    PubMed     Abstract available


  218. VEDOVATO N, Salguero MV, Greeley SAW, Yu CH, et al
    A loss-of-function mutation in KCNJ11 causing sulfonylurea-sensitive diabetes in early adult life.
    Diabetologia. 2024 Feb 17. doi: 10.1007/s00125-024-06103.
    PubMed     Abstract available


  219. JANCEV M, Vissers TACM, Visseren FLJ, van Bon AC, et al
    Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis.
    Diabetologia. 2024 Feb 16. doi: 10.1007/s00125-024-06107.
    PubMed     Abstract available


  220. KENGNE AP, Ramachandran A
    Feasibility of prevention of type 2 diabetes in low- and middle-income countries.
    Diabetologia. 2024 Feb 15. doi: 10.1007/s00125-023-06085.
    PubMed     Abstract available


  221. TEIXEIRA PF, Battelino T, Carlsson A, Gudbjornsdottir S, et al
    Assisting the implementation of screening for type 1 diabetes by using artificial intelligence on publicly available data.
    Diabetologia. 2024 Feb 14. doi: 10.1007/s00125-024-06089.
    PubMed     Abstract available


  222. BLUHER M, Rosenstock J, Hoefler J, Manuel R, et al
    Correction to: Dose-response effects on HbA(1c) and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial.
    Diabetologia. 2024 Feb 13. doi: 10.1007/s00125-024-06095.
    PubMed    


  223. GUO M, Guo H, Zhu J, Wang F, et al
    A novel subpopulation of monocytes with a strong interferon signature indicated by SIGLEC-1 is present in patients with in recent-onset type 1 diabetes.
    Diabetologia. 2024 Feb 13. doi: 10.1007/s00125-024-06098.
    PubMed     Abstract available


  224. KURGAN N, Kjaergaard Larsen J, Deshmukh AS
    Harnessing the power of proteomics in precision diabetes medicine.
    Diabetologia. 2024 Feb 12. doi: 10.1007/s00125-024-06097.
    PubMed     Abstract available


  225. HOEK AG, Dal Canto E, Wenker E, Bindraban N, et al
    Epidemiology of heart failure in diabetes: a disease in disguise.
    Diabetologia. 2024 Feb 9. doi: 10.1007/s00125-023-06068.
    PubMed     Abstract available


  226. QADRI S, Yki-Jarvinen H
    Surveillance of the liver in type 2 diabetes: important but unfeasible?
    Diabetologia. 2024 Feb 9. doi: 10.1007/s00125-024-06087.
    PubMed     Abstract available


  227. SAVARESE G, Lindberg F, Filippatos G, Butler J, et al
    Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists.
    Diabetologia. 2024;67:246-262.
    PubMed     Abstract available


  228. MISKELLY MG, Lindqvist A, Piccinin E, Hamilton A, et al
    RNA sequencing unravels novel L cell constituents and mechanisms of GLP-1 secretion in human gastric bypass-operated intestine.
    Diabetologia. 2024;67:356-370.
    PubMed     Abstract available


  229. TANNER HL, Ng HT, Murphy G, Barrett HL, et al
    Habitual carbohydrate intake is not correlated with circulating beta-hydroxybutyrate levels in pregnant women with overweight and obesity at 28 weeks' gestation.
    Diabetologia. 2024;67:346-355.
    PubMed     Abstract available


    January 2024
  230. ASEMI Z, Karamali M, Esmaillzadeh A
    Editorial Expression of Concern: Effects of calcium-vitamin D co-supplementation on glycaemic control, inflammation and oxidative stress in gestational diabetes: a randomised placebo-controlled trial.
    Diabetologia. 2024 Jan 30. doi: 10.1007/s00125-023-06077.
    PubMed    


  231. GARCIA R, Schroder LC, Tavernier M, Gand E, et al
    QRS-T angle: is it a specific parameter associated with sudden cardiac death in type 2 diabetes? Results from the SURDIAGENE and the Mini-Finland prospective cohorts.
    Diabetologia. 2024 Jan 24. doi: 10.1007/s00125-023-06074.
    PubMed     Abstract available


  232. SAMUELSSON J, Bertilsson R, Bulow E, Carlsson S, et al
    Autoimmune comorbidity in type 1 diabetes and its association with metabolic control and mortality risk in young people: a population-based study.
    Diabetologia. 2024 Jan 22. doi: 10.1007/s00125-024-06086.
    PubMed     Abstract available


  233. RAUBENHEIMER PJ, Skelton J, Peya B, Dave JA, et al
    Phenotype and predictors of insulin independence in adults presenting with diabetic ketoacidosis: a prospective cohort study.
    Diabetologia. 2024 Jan 19. doi: 10.1007/s00125-023-06067.
    PubMed     Abstract available


  234. SHAO M, Chen D, Wang Q, Guo F, et al
    Canagliflozin regulates metabolic reprogramming in diabetic kidney disease by inducing fasting-like and aestivation-like metabolic patterns.
    Diabetologia. 2024 Jan 18. doi: 10.1007/s00125-023-06078.
    PubMed     Abstract available


  235. VISSER MM, Van Muylder A, Charleer S, Isitt JJ, et al
    Cost-utility analysis of Dexcom G6 real-time continuous glucose monitoring versus FreeStyle Libre 1 intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in Belgium.
    Diabetologia. 2024 Jan 18. doi: 10.1007/s00125-023-06084.
    PubMed     Abstract available


  236. TUOMELA K, Levings MK
    Genetic engineering of regulatory T cells for treatment of autoimmune disorders including type 1 diabetes.
    Diabetologia. 2024 Jan 18. doi: 10.1007/s00125-023-06076.
    PubMed     Abstract available


  237. GREGG EW, Chen H, Bancks MP, Manalac R, et al
    Impact of remission from type 2 diabetes on long-term health outcomes: findings from the Look AHEAD study.
    Diabetologia. 2024 Jan 18. doi: 10.1007/s00125-023-06048.
    PubMed     Abstract available


  238. ALZUBAIDI H, Oliveira VH, Samorinha C, Mc Namara K, et al
    Acculturation and glycaemic control in Arab immigrants with type 2 diabetes in Australia.
    Diabetologia. 2024 Jan 12. doi: 10.1007/s00125-023-06081.
    PubMed     Abstract available


  239. BRUZZANITI S, Piemonte E, Bruzzese D, Lepore MT, et al
    Progression of type 1 diabetes is associated with high levels of soluble PD-1 in islet autoantibody-positive children.
    Diabetologia. 2024 Jan 12. doi: 10.1007/s00125-023-06075.
    PubMed     Abstract available


  240. HUMMEL S, Rosenberger S, von dem Berge T, Besser REJ, et al
    Early-childhood body mass index and its association with the COVID-19 pandemic, containment measures and islet autoimmunity in children with increased risk for type 1 diabetes.
    Diabetologia. 2024 Jan 12. doi: 10.1007/s00125-023-06079.
    PubMed     Abstract available


  241. CASTILLO-ARMENGOL J, Marzetta F, Sanchez-Archidona AR, Fledelius C, et al
    Correction to: Disrupted hypothalamic transcriptomics and proteomics in a mouse model of type 2 diabetes exposed to recurrent hypoglycaemia.
    Diabetologia. 2024 Jan 11. doi: 10.1007/s00125-023-06083.
    PubMed    


  242. WERKMAN NCC, Garcia-Saez G, Nielen JTH, Tapia-Galisteo J, et al
    Disease severity-based subgrouping of type 2 diabetes does not parallel differences in quality of life: the Maastricht Study.
    Diabetologia. 2024 Jan 11. doi: 10.1007/s00125-023-06082.
    PubMed     Abstract available


  243. DHANAPALARATNAM R, Issar T, Lee ATK, Poynten AM, et al
    Glucagon-like peptide-1 receptor agonists reverse nerve morphological abnormalities in diabetic peripheral neuropathy.
    Diabetologia. 2024 Jan 8. doi: 10.1007/s00125-023-06072.
    PubMed     Abstract available


  244. ROTHBERG A, Lean M, Laferrere B
    Remission of type 2 diabetes: always more questions, but enough answers for action.
    Diabetologia. 2024 Jan 8. doi: 10.1007/s00125-023-06069.
    PubMed     Abstract available


  245. FERNANDEZ-VELEDO S, Marsal-Beltran A, Vendrell J
    Type 2 diabetes and succinate: unmasking an age-old molecule.
    Diabetologia. 2024 Jan 5. doi: 10.1007/s00125-023-06063.
    PubMed     Abstract available


  246. AHMED R, de Souza RJ, Li V, Banfield L, et al
    Twenty years of participation of racialised groups in type 2 diabetes randomised clinical trials: a meta-epidemiological review.
    Diabetologia. 2024 Jan 4. doi: 10.1007/s00125-023-06052.
    PubMed     Abstract available


  247. PENALVO JL
    The impact of taxing sugar-sweetened beverages on diabetes: a critical review.
    Diabetologia. 2024 Jan 4. doi: 10.1007/s00125-023-06064.
    PubMed     Abstract available


  248. PAZ-BARBA M, Munoz Garcia A, de Winter TJJ, de Graaf N, et al
    Apolipoprotein L genes are novel mediators of inflammation in beta cells.
    Diabetologia. 2024;67:124-136.
    PubMed     Abstract available


  249. REN L, Charbord J, Chu L, Kemas AM, et al
    Adjudin improves beta cell maturation, hepatic glucose uptake and glucose homeostasis.
    Diabetologia. 2024;67:137-155.
    PubMed     Abstract available


  250. CHHABRA KH, Bathina S, Faniyan TS, Samuel DJ, et al
    ADGRL1 is a glucose receptor involved in mediating energy and glucose homeostasis.
    Diabetologia. 2024;67:170-189.
    PubMed     Abstract available


    December 2023
  251. KRISHNAN A, Schneider CV, Hadi Y, Mukherjee D, et al
    Cardiovascular and mortality outcomes with GLP-1 receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study.
    Diabetologia. 2023 Dec 20. doi: 10.1007/s00125-023-06057.
    PubMed     Abstract available


  252. BASSET-SAGARMINAGA J, van de Weijer T, Iozzo P, Schrauwen P, et al
    Advances and challenges in measuring hepatic glucose uptake with FDG PET: implications for diabetes research.
    Diabetologia. 2023 Dec 15. doi: 10.1007/s00125-023-06055.
    PubMed     Abstract available


  253. EMANUELSSON F, Afzal S, Jorgensen NR, Nordestgaard BG, et al
    Hyperglycaemia, diabetes and risk of fragility fractures: observational and Mendelian randomisation studies.
    Diabetologia. 2023 Dec 14. doi: 10.1007/s00125-023-06054.
    PubMed     Abstract available


  254. BLUHER M, Rosenstock J, Hoefler J, Manuel R, et al
    Dose-response effects on HbA(1c) and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial.
    Diabetologia. 2023 Dec 14. doi: 10.1007/s00125-023-06053.
    PubMed     Abstract available


  255. CARRASQUILLA GD, Angquist L, Sorensen TIA, Kilpelainen TO, et al
    Child-to-adult body size change and risk of type 2 diabetes and cardiovascular disease.
    Diabetologia. 2023 Dec 12. doi: 10.1007/s00125-023-06058.
    PubMed     Abstract available


  256. MEULEBROUCK S, Scherrer V, Boutry R, Toussaint B, et al
    Pathogenic monoallelic variants in GLIS3 increase type 2 diabetes risk and identify a subgroup of patients sensitive to sulfonylureas.
    Diabetologia. 2023 Dec 5. doi: 10.1007/s00125-023-06035.
    PubMed     Abstract available


  257. JENDLE J, Adolfsson P, Choudhary P, Dovc K, et al
    A narrative commentary about interoperability in medical devices and data used in diabetes therapy from an academic EU/UK/US perspective.
    Diabetologia. 2023 Dec 2. doi: 10.1007/s00125-023-06049.
    PubMed     Abstract available


  258. CROMER SJ, Thaweethai T, Wexler DJ
    Racial/ethnic and socioeconomic disparities in achievement of treatment goals within a clinical trial: a secondary analysis of the ACCORD trial.
    Diabetologia. 2023;66:2261-2274.
    PubMed     Abstract available


    November 2023
  259. CORPELEIJN WE, de Waal WJ, Schipper HS, Wiegman A, et al
    Dyslipidaemia as a target for atherosclerotic cardiovascular disease prevention in children with type 1 diabetes: lessons learned from familial hypercholesterolaemia.
    Diabetologia. 2023 Nov 30. doi: 10.1007/s00125-023-06041.
    PubMed     Abstract available


  260. GAJECKA M, Gutaj P, Jaskiewicz K, Rydzanicz M, et al
    Effects of maternal type 1 diabetes and confounding factors on neonatal microbiomes.
    Diabetologia. 2023 Nov 29. doi: 10.1007/s00125-023-06047.
    PubMed     Abstract available


  261. MOOSHAGE CM, Tsilingiris D, Schimpfle L, Seebauer L, et al
    A diminished sciatic nerve structural integrity is associated with distinct peripheral sensory phenotypes in individuals with type 2 diabetes.
    Diabetologia. 2023 Nov 29. doi: 10.1007/s00125-023-06050.
    PubMed     Abstract available


  262. CASTILLO-ARMENGOL J, Marzetta F, Rodriguez Sanchez-Archidona A, Fledelius C, et al
    Disrupted hypothalamic transcriptomics and proteomics in a mouse model of type 2 diabetes exposed to recurrent hypoglycaemia.
    Diabetologia. 2023 Nov 28. doi: 10.1007/s00125-023-06043.
    PubMed     Abstract available


  263. FARRELL CM, McNeilly AD, Hapca S, Fournier PA, et al
    High intensity interval training as a novel treatment for impaired awareness of hypoglycaemia in people with type 1 diabetes (HIT4HYPOS): a randomised parallel-group study.
    Diabetologia. 2023 Nov 27. doi: 10.1007/s00125-023-06051.
    PubMed     Abstract available


  264. MACKENZIE SC, Sainsbury CAR, Wake DJ
    Diabetes and artificial intelligence beyond the closed loop: a review of the landscape, promise and challenges.
    Diabetologia. 2023 Nov 18. doi: 10.1007/s00125-023-06038.
    PubMed     Abstract available


  265. TRICO D, Masoni MC, Baldi S, Cimbalo N, et al
    Early time-restricted carbohydrate consumption vs conventional dieting in type 2 diabetes: a randomised controlled trial.
    Diabetologia. 2023 Nov 16. doi: 10.1007/s00125-023-06045.
    PubMed     Abstract available


  266. VYAKARANAM AR, Mahamed MM, Hellman P, Eriksson O, et al
    Non-invasive imaging of sympathetic innervation of the pancreas in individuals with type 2 diabetes.
    Diabetologia. 2023 Nov 7. doi: 10.1007/s00125-023-06039.
    PubMed     Abstract available


  267. DRENTHEN LCA, de Baaij JHF, Rodwell L, van Herwaarden AE, et al
    Oral magnesium supplementation does not affect insulin sensitivity in people with insulin-treated type 2 diabetes and a low serum magnesium: a randomised controlled trial.
    Diabetologia. 2023 Nov 3. doi: 10.1007/s00125-023-06029.
    PubMed     Abstract available


  268. PETRELLI A, Cugnata F, Carnovale D, Bosi E, et al
    HOMA-IR and the Matsuda Index as predictors of progression to type 1 diabetes in autoantibody-positive relatives.
    Diabetologia. 2023 Nov 2. doi: 10.1007/s00125-023-06034.
    PubMed     Abstract available


  269. HUGHES AE, Houghton JAL, Bunce B, Chakera AJ, et al
    Bringing precision medicine to the management of pregnancy in women with glucokinase-MODY: a study of diagnostic accuracy and feasibility of non-invasive prenatal testing.
    Diabetologia. 2023;66:1997-2006.
    PubMed     Abstract available


  270. YAVOROV-DAYLIEV D, Milagro FI, Ayo J, Oneca M, et al
    Glucose-lowering effects of a synbiotic combination containing Pediococcus acidilactici in C. elegans and mice.
    Diabetologia. 2023;66:2117-2138.
    PubMed     Abstract available


  271. THOMAIDOU S, Munoz Garcia A, de Lange S, Gan J, et al
    IFN? but not IFNalpha increases recognition of insulin defective ribosomal product-derived antigen to amplify islet autoimmunity.
    Diabetologia. 2023;66:2075-2086.
    PubMed     Abstract available


  272. IIDA H, Kono T, Lee CC, Krishnan P, et al
    SERCA2 regulates proinsulin processing and processing enzyme maturation in pancreatic beta cells.
    Diabetologia. 2023;66:2042-2061.
    PubMed     Abstract available


  273. SKRIVER C, Friis S, Knudsen LB, Catarig AM, et al
    Potential preventive properties of GLP-1 receptor agonists against prostate cancer: a nationwide cohort study.
    Diabetologia. 2023;66:2007-2016.
    PubMed     Abstract available


    October 2023
  274. DE HASE EM, Neyrinck AM, Rodriguez J, Cnop M, et al
    Impact of metformin and Dysosmobacter welbionis on diet-induced obesity and diabetes: from clinical observation to preclinical intervention.
    Diabetologia. 2023 Oct 28. doi: 10.1007/s00125-023-06032.
    PubMed     Abstract available


  275. AMARATUNGA SA, Hussein Tayeb T, Muhamad Sediq RN, Hama Salih FK, et al
    Paediatric diabetes subtypes in a consanguineous population: a single-centre cohort study from Kurdistan, Iraq.
    Diabetologia. 2023 Oct 28. doi: 10.1007/s00125-023-06030.
    PubMed     Abstract available


  276. CARRASCO-ZANINI J, Pietzner M, Wheeler E, Kerrison ND, et al
    Multi-omic prediction of incident type 2 diabetes.
    Diabetologia. 2023 Oct 27. doi: 10.1007/s00125-023-06027.
    PubMed     Abstract available


  277. ZHONG T, He B, Li X, Lei K, et al
    Glycaemia risk index uncovers distinct glycaemic variability patterns associated with remission status in type 1 diabetes.
    Diabetologia. 2023 Oct 27. doi: 10.1007/s00125-023-06042.
    PubMed     Abstract available


  278. HATANO Y, VanWagner LB, Carnethon MR, Bancks MP, et al
    Using race as a social construct when looking at differences in racial associations between non?alcoholic fatty liver disease and type 2 diabetes. Reply to Rollin FG, Washington C, Fluker S-A [letter].
    Diabetologia. 2023 Oct 26. doi: 10.1007/s00125-023-06024.
    PubMed    


  279. CORBIN LJ, Hughes DA, Bull CJ, Vincent EE, et al
    The metabolomic signature of weight loss and remission in the Diabetes Remission Clinical Trial (DiRECT).
    Diabetologia. 2023 Oct 25. doi: 10.1007/s00125-023-06019.
    PubMed     Abstract available


  280. BOWDEN N, Dixon R, Anderson V, de Bock M, et al
    Associations between type 1 diabetes and educational outcomes: an Aotearoa/New Zealand nationwide birth cohort study using the Integrated Data Infrastructure.
    Diabetologia. 2023 Oct 23. doi: 10.1007/s00125-023-06026.
    PubMed     Abstract available


  281. ELLIOTT J, Sloan G, Stevens L, Selvarajah D, et al
    Female sex is a risk factor for painful diabetic peripheral neuropathy: the EURODIAB prospective diabetes complications study.
    Diabetologia. 2023 Oct 23. doi: 10.1007/s00125-023-06025.
    PubMed     Abstract available


  282. LEE DH, Jin Q, Shi N, Wang F, et al
    The metabolic potential of inflammatory and insulinaemic dietary patterns and risk of type 2 diabetes.
    Diabetologia. 2023 Oct 11. doi: 10.1007/s00125-023-06021.
    PubMed     Abstract available


  283. SRIDHAR VS, Limonte CP, Groop PH, Heerspink HJL, et al
    Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetes.
    Diabetologia. 2023 Oct 6. doi: 10.1007/s00125-023-06015.
    PubMed     Abstract available


  284. SVALASTOGA P, Kaci A, Molnes J, Solheim MH, et al
    Characterisation of HNF1A variants in paediatric diabetes in Norway using functional and clinical investigations to unmask phenotype and monogenic diabetes.
    Diabetologia. 2023 Oct 5. doi: 10.1007/s00125-023-06012.
    PubMed     Abstract available


  285. YARDLEY JE, Govette A, Laesser CI, Lespagnol E, et al
    Sex influences health: reporting on female characteristics should be mandatory in exercise and physical activity-related diabetes research.
    Diabetologia. 2023 Oct 5. doi: 10.1007/s00125-023-06022.
    PubMed    


  286. MATHIEU C, Wiedeman A, Cerosaletti K, Long SA, et al
    A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab.
    Diabetologia. 2023 Oct 2. doi: 10.1007/s00125-023-06014.
    PubMed     Abstract available


  287. ANDREASEN CR, Andersen A, Vilsboll T
    The future of incretins in the treatment of obesity and non-alcoholic fatty liver disease.
    Diabetologia. 2023;66:1846-1858.
    PubMed     Abstract available


  288. KARAGIANNIS T, Bekiari E, Tsapas A
    Socioeconomic aspects of incretin-based therapy.
    Diabetologia. 2023;66:1859-1868.
    PubMed     Abstract available


  289. TSCHOP M, Nogueiras R, Ahren B
    Gut hormone-based pharmacology: novel formulations and future possibilities for metabolic disease therapy.
    Diabetologia. 2023;66:1796-1808.
    PubMed     Abstract available


  290. DRUCKER DJ, Holst JJ
    The expanding incretin universe: from basic biology to clinical translation.
    Diabetologia. 2023;66:1765-1779.
    PubMed     Abstract available


    September 2023
  291. WADSTROM BN, Pedersen KM, Wulff AB, Nordestgaard BG, et al
    Elevated remnant cholesterol and atherosclerotic cardiovascular disease in diabetes: a population-based prospective cohort study.
    Diabetologia. 2023 Sep 30. doi: 10.1007/s00125-023-06016.
    PubMed     Abstract available


  292. TASKINEN MR, Matikainen N, Bjornson E, Soderlund S, et al
    Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy.
    Diabetologia. 2023 Sep 29. doi: 10.1007/s00125-023-06008.
    PubMed     Abstract available


  293. RUISSEN MM, Torres-Pena JD, Uitbeijerse BS, Arenas de Larriva AP, et al
    Clinical impact of an integrated e-health system for diabetes self-management support and shared decision making (POWER2DM): a randomised controlled trial.
    Diabetologia. 2023 Sep 29. doi: 10.1007/s00125-023-06006.
    PubMed     Abstract available


  294. MITA T, Katakami N, Okada Y, Yoshii H, et al
    Continuous glucose monitoring-derived time in range and CV are associated with altered tissue characteristics of the carotid artery wall in people with type 2 diabetes.
    Diabetologia. 2023 Sep 26. doi: 10.1007/s00125-023-06013.
    PubMed     Abstract available


  295. SCHNEIDER J, Gemulla G, Kiess W, Berner R, et al
    Presymptomatic type 1 diabetes and disease severity at onset.
    Diabetologia. 2023 Sep 26. doi: 10.1007/s00125-023-05999.
    PubMed    


  296. THOMAS NJ, Jones AG
    The challenges of identifying and studying type 1 diabetes in adults.
    Diabetologia. 2023 Sep 20. doi: 10.1007/s00125-023-06004.
    PubMed     Abstract available


  297. HU X, Buhl CS, Sjogaard MB, Schousboe K, et al
    Structural changes in Schwann cells and nerve fibres in type 1 diabetes: relationship with diabetic polyneuropathy.
    Diabetologia. 2023 Sep 20. doi: 10.1007/s00125-023-06009.
    PubMed     Abstract available


  298. TIAN C, Burki C, Westerman KE, Patel CJ, et al
    Association between timing and consistency of physical activity and type 2 diabetes: a cohort study on participants of the UK Biobank.
    Diabetologia. 2023 Sep 20. doi: 10.1007/s00125-023-06001.
    PubMed     Abstract available


  299. WRIGHT DM, Chakravarthy U, Das R, Graham KW, et al
    Identifying the severity of diabetic retinopathy by visual function measures using both traditional statistical methods and interpretable machine learning: a cross-sectional study.
    Diabetologia. 2023 Sep 19. doi: 10.1007/s00125-023-06005.
    PubMed     Abstract available


  300. HUMMEL S, Friedl N, Winkler C, Ziegler AG, et al
    Presymptomatic type 1 diabetes and disease severity at onset. Reply to Schneider J, Gemulla G, Kiess W et al [letter].
    Diabetologia. 2023 Sep 19. doi: 10.1007/s00125-023-06017.
    PubMed    


  301. GALDERISI A, Carr ALJ, Martino M, Taylor P, et al
    Quantifying beta cell function in the preclinical stages of type 1 diabetes.
    Diabetologia. 2023 Sep 15. doi: 10.1007/s00125-023-06011.
    PubMed     Abstract available


  302. BONORA BM, Morieri ML, Marassi M, Cappellari R, et al
    Improved prediction of long-term kidney outcomes in people with type 2 diabetes by levels of circulating haematopoietic stem/progenitor cells.
    Diabetologia. 2023 Sep 15. doi: 10.1007/s00125-023-06002.
    PubMed     Abstract available


  303. ROLLIN FG, Washington C, Fluker SA
    Using race as a social construct when looking at differences in racial associations between non-alcoholic fatty liver disease and type 2 diabetes.
    Diabetologia. 2023 Sep 7. doi: 10.1007/s00125-023-05998.
    PubMed    


  304. DHARMARAJAN S, Carrillo C, Qi Z, Wilson JM, et al
    Retinal inflammation in murine models of type 1 and type 2 diabetes with diabetic retinopathy.
    Diabetologia. 2023 Sep 5. doi: 10.1007/s00125-023-05995.
    PubMed     Abstract available


  305. SIMS EK, Geyer SM, Long SA, Herold KC, et al
    High proinsulin:C-peptide ratio identifies individuals with stage 2 type 1 diabetes at high risk for progression to clinical diagnosis and responses to teplizumab treatment.
    Diabetologia. 2023 Sep 4. doi: 10.1007/s00125-023-06003.
    PubMed     Abstract available



  306. 59(th) EASD Annual Meeting of the European Association for the Study of Diabetes : Hamburg, Germany, 2 - 6 October 2023.
    Diabetologia. 2023 Sep 4. doi: 10.1007/s00125-023-05969.
    PubMed    


    August 2023
  307. LI JM, Li X, Chan LWC, Hu R, et al
    Lipotoxicity-polarised macrophage-derived exosomes regulate mitochondrial fitness through Miro1-mediated mitophagy inhibition and contribute to type 2 diabetes development in mice.
    Diabetologia. 2023 Aug 24. doi: 10.1007/s00125-023-05992.
    PubMed     Abstract available


  308. MEEK CL, Stewart ZA, Feig DS, Furse S, et al
    Metabolomic insights into maternal and neonatal complications in pregnancies affected by type 1 diabetes.
    Diabetologia. 2023 Aug 24. doi: 10.1007/s00125-023-05989.
    PubMed     Abstract available


  309. RETNAKARAN R, Ye C, Kramer CK, Hanley AJ, et al
    Deteriorating beta cell function is the dominant determinant of progression from normal glucose tolerance to prediabetes/diabetes in young women following pregnancy.
    Diabetologia. 2023 Aug 24. doi: 10.1007/s00125-023-05994.
    PubMed     Abstract available


  310. GOLDNEY J, Sargeant JA, Davies MJ
    Incretins and microvascular complications of diabetes: neuropathy, nephropathy, retinopathy and microangiopathy.
    Diabetologia. 2023 Aug 19. doi: 10.1007/s00125-023-05988.
    PubMed     Abstract available


  311. MOKHTAR SBA, van der Heide FCT, Oyaert KAM, van der Kallen CJH, et al
    (Pre)diabetes and a higher level of glycaemic measures are continuously associated with corneal neurodegeneration assessed by corneal confocal microscopy: the Maastricht Study.
    Diabetologia. 2023 Aug 17. doi: 10.1007/s00125-023-05986.
    PubMed     Abstract available


  312. OOSTVEEN RF, Kaiser Y, Stahle MR, Nurmohamed NS, et al
    Atorvastatin lowers (68)Ga-DOTATATE uptake in coronary arteries, bone marrow and spleen in individuals with type 2 diabetes.
    Diabetologia. 2023 Aug 15. doi: 10.1007/s00125-023-05990.
    PubMed     Abstract available


  313. ZHAO X, Zhang X, Pei J, Liu Y, et al
    Targeting BCAA metabolism to potentiate metformin's therapeutic efficacy in the treatment of diabetes in mice.
    Diabetologia. 2023 Aug 15. doi: 10.1007/s00125-023-05985.
    PubMed     Abstract available


  314. MATHIEU C, Ahmadzai I
    Incretins beyond type 2 diabetes.
    Diabetologia. 2023 Aug 8. doi: 10.1007/s00125-023-05980.
    PubMed     Abstract available


  315. SOLINI A, Trico D, Del Prato S
    Incretins and cardiovascular disease: to the heart of type 2 diabetes?
    Diabetologia. 2023 Aug 5. doi: 10.1007/s00125-023-05973.
    PubMed     Abstract available


  316. MOULDER R, Valikangas T, Hirvonen MK, Suomi T, et al
    Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes distinguishes markers of disease and C-peptide trajectory.
    Diabetologia. 2023 Aug 4. doi: 10.1007/s00125-023-05974.
    PubMed     Abstract available


  317. TANG H, Wang J, Deng P, Li Y, et al
    Transcriptome-wide association study-derived genes as potential visceral adipose tissue-specific targets for type 2 diabetes.
    Diabetologia. 2023 Aug 4. doi: 10.1007/s00125-023-05978.
    PubMed     Abstract available


  318. FALKENTOFT AC, Gerds TA, Zareini B, Knop FK, et al
    Risk of first-time major cardiovascular event among individuals with newly diagnosed type 2 diabetes: data from Danish registers.
    Diabetologia. 2023 Aug 2. doi: 10.1007/s00125-023-05977.
    PubMed     Abstract available


  319. WEWER ALBRECHTSEN NJ, Holst JJ, Cherrington AD, Finan B, et al
    100 years of glucagon and 100 more.
    Diabetologia. 2023;66:1378-1394.
    PubMed     Abstract available


  320. YARMOLINSKY J, Bouras E, Constantinescu A, Burrows K, et al
    Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis.
    Diabetologia. 2023;66:1481-1500.
    PubMed     Abstract available


    July 2023
  321. ANSON M, Zhao SS, Austin P, Ibarburu GH, et al
    SGLT2i and GLP-1 RA therapy in type 1 diabetes and reno-vascular outcomes: a real-world study.
    Diabetologia. 2023 Jul 28. doi: 10.1007/s00125-023-05975.
    PubMed     Abstract available


  322. KOSJERINA V, Carstensen B, Amadid H, Vistisen D, et al
    Glycaemic control, risk of hypoglycaemia and all-cause mortality in new users of second-generation basal insulin with type 2 diabetes and chronic kidney disease: a nationwide register-based cohort study.
    Diabetologia. 2023 Jul 28. doi: 10.1007/s00125-023-05971.
    PubMed     Abstract available


  323. KOBAYASHI Y, Long J, Dan S, Johannsen NM, et al
    Strength training is more effective than aerobic exercise for improving glycaemic control and body composition in people with normal-weight type 2 diabetes: a randomised controlled trial.
    Diabetologia. 2023 Jul 26. doi: 10.1007/s00125-023-05958.
    PubMed     Abstract available


  324. THOMPSON PJ, Pipella J, Rutter GA, Gaisano HY, et al
    Islet autoimmunity in human type 1 diabetes: initiation and progression from the perspective of the beta cell.
    Diabetologia. 2023 Jul 25. doi: 10.1007/s00125-023-05970.
    PubMed     Abstract available


  325. RIAHI Y, Kogot-Levin A, Kadosh L, Agranovich B, et al
    Hyperglucagonaemia in diabetes: altered amino acid metabolism triggers mTORC1 activation, which drives glucagon production.
    Diabetologia. 2023 Jul 22. doi: 10.1007/s00125-023-05967.
    PubMed     Abstract available


  326. GARRIB A, Kivuyo S, Bates K, Ramaiya K, et al
    Metformin for the prevention of diabetes among people with HIV and either impaired fasting glucose or impaired glucose tolerance (prediabetes) in Tanzania: a Phase II randomised placebo-controlled trial.
    Diabetologia. 2023 Jul 18. doi: 10.1007/s00125-023-05968.
    PubMed     Abstract available


  327. SHAH R, Spektor TM, Weisenberger DJ, Ding H, et al
    Reversal of dual epigenetic repression of non-canonical Wnt-5a normalises diabetic corneal epithelial wound healing and stem cells.
    Diabetologia. 2023 Jul 18. doi: 10.1007/s00125-023-05960.
    PubMed     Abstract available


  328. LYSSENKO V, Vaag A
    Genetics of diabetes-associated microvascular complications.
    Diabetologia. 2023 Jul 14. doi: 10.1007/s00125-023-05964.
    PubMed     Abstract available


  329. LUCKETT AM, Weedon MN, Hawkes G, Leslie RD, et al
    Utility of genetic risk scores in type 1 diabetes.
    Diabetologia. 2023 Jul 13. doi: 10.1007/s00125-023-05955.
    PubMed     Abstract available


  330. MEEK CL
    An unwelcome inheritance: childhood obesity after diabetes in pregnancy.
    Diabetologia. 2023 Jul 13. doi: 10.1007/s00125-023-05965.
    PubMed     Abstract available


  331. NAUCK MA, Muller TD
    Incretin hormones and type 2 diabetes.
    Diabetologia. 2023 Jul 11. doi: 10.1007/s00125-023-05956.
    PubMed     Abstract available


  332. LI JH, Brenner LN, Kaur V, Figueroa K, et al
    Genome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH.
    Diabetologia. 2023;66:1260-1272.
    PubMed     Abstract available


  333. YANG W, Liao W, Li X, Ai W, et al
    Hepatic p38alpha MAPK controls gluconeogenesis via FOXO1 phosphorylation at S273 during glucagon signalling in mice.
    Diabetologia. 2023;66:1322-1339.
    PubMed     Abstract available


  334. GORGOGIETAS V, Rajaei B, Heeyoung C, Santacreu BJ, et al
    GLP-1R agonists demonstrate potential to treat Wolfram syndrome in human preclinical models.
    Diabetologia. 2023;66:1306-1321.
    PubMed     Abstract available


  335. DE RITTER R, Stehouwer CDA
    Further investigation of the association between diabetes status and body composition and whether this association is moderated by sex. Reply to Mai Y [letter].
    Diabetologia. 2023 Jul 1. doi: 10.1007/s00125-023-05959.
    PubMed    


    June 2023
  336. FAN M, Stephan AJ, Emmert-Fees K, Peters A, et al
    Health and economic impact of improved glucose, blood pressure and lipid control among German adults with type 2 diabetes: a modelling study.
    Diabetologia. 2023 Jun 30. doi: 10.1007/s00125-023-05950.
    PubMed     Abstract available


  337. LITTLE K, Singh A, Del Marco A, Llorian-Salvador M, et al
    Disruption of cortical cell type composition and function underlies diabetes-associated cognitive decline.
    Diabetologia. 2023 Jun 23. doi: 10.1007/s00125-023-05935.
    PubMed     Abstract available


  338. KUSS O, Opitz ME, Brandstetter LV, Schlesinger S, et al
    How amenable is type 2 diabetes treatment for precision diabetology? A meta-regression of glycaemic control data from 174 randomised trials.
    Diabetologia. 2023 Jun 20. doi: 10.1007/s00125-023-05951.
    PubMed     Abstract available


  339. HUMMEL S, Carl J, Friedl N, Winkler C, et al
    Children diagnosed with presymptomatic type 1 diabetes through public health screening have milder diabetes at clinical manifestation.
    Diabetologia. 2023 Jun 17. doi: 10.1007/s00125-023-05953.
    PubMed     Abstract available


  340. MAI Y
    Further investigation of the association between diabetes status and body composition and whether this association is moderated by sex.
    Diabetologia. 2023 Jun 15. doi: 10.1007/s00125-023-05919.
    PubMed    


  341. HAMMER SS, Dorweiler TF, McFarland D, Adu-Agyeiwaah Y, et al
    Cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy.
    Diabetologia. 2023 Jun 14. doi: 10.1007/s00125-023-05949.
    PubMed     Abstract available


  342. PIEBER TR, Arfelt KN, Cailleteau R, Hart M, et al
    Hypoglycaemia frequency and physiological response after double or triple doses of once-weekly insulin icodec vs once-daily insulin glargine U100 in type 2 diabetes: a randomised crossover trial.
    Diabetologia. 2023 Jun 13. doi: 10.1007/s00125-023-05921.
    PubMed     Abstract available


  343. LUO H, Bauer A, Nano J, Petrera A, et al
    Associations of plasma proteomics with type 2 diabetes and related traits: results from the longitudinal KORA S4/F4/FF4 Study.
    Diabetologia. 2023 Jun 13. doi: 10.1007/s00125-023-05943.
    PubMed     Abstract available


  344. WIBAEK R, Andersen GS, Linneberg A, Hansen T, et al
    Low birthweight is associated with a higher incidence of type 2 diabetes over two decades independent of adult BMI and genetic predisposition.
    Diabetologia. 2023 Jun 12. doi: 10.1007/s00125-023-05937.
    PubMed     Abstract available


  345. HANSEN AL, Thomsen RW, Brons C, Svane HML, et al
    Birthweight is associated with clinical characteristics in people with recently diagnosed type 2 diabetes.
    Diabetologia. 2023 Jun 12. doi: 10.1007/s00125-023-05936.
    PubMed     Abstract available


  346. SIERRA-SILVESTRE E, Andrade RJ, Holguin-Colorado L, Edwards K, et al
    Occurrence of corneal sub-epithelial microneuromas and axonal swelling in people with diabetes with and without (painful) diabetic neuropathy.
    Diabetologia. 2023 Jun 10:1-16. doi: 10.1007/s00125-023-05945.
    PubMed     Abstract available


  347. LAMPOUSI AM, Carlsson S, Lofvenborg JE, Cabrera-Castro N, et al
    Interaction between plasma phospholipid odd-chain fatty acids and GAD65 autoantibodies on the incidence of adult-onset diabetes: the EPIC-InterAct case-cohort study.
    Diabetologia. 2023 Jun 10. doi: 10.1007/s00125-023-05948.
    PubMed     Abstract available


  348. TANG R, Zhong T, Lei K, Lin X, et al
    Recovery of intracellular glucose uptake in T cells during partial remission of type 1 diabetes.
    Diabetologia. 2023 Jun 10. doi: 10.1007/s00125-023-05938.
    PubMed     Abstract available


  349. BROSSAUD J, Bosch-Bouju C, Marissal-Arvy N, Campas-Lebecque MN, et al
    Memory deficits in a juvenile rat model of type 1 diabetes are due to excess 11beta-HSD1 activity, which is upregulated by high glucose concentrations rather than insulin deficiency.
    Diabetologia. 2023 Jun 10. doi: 10.1007/s00125-023-05942.
    PubMed     Abstract available


  350. HAWKES G, Beaumont RN, Tyrrell J, Power GM, et al
    Genetic evidence that high BMI in childhood has a protective effect on intermediate diabetes traits, including measures of insulin sensitivity and secretion, after accounting for BMI in adulthood.
    Diabetologia. 2023 Jun 6. doi: 10.1007/s00125-023-05923.
    PubMed     Abstract available


  351. SIMO R, Hernandez C
    What else can we do to prevent diabetic retinopathy?
    Diabetologia. 2023 Jun 6. doi: 10.1007/s00125-023-05940.
    PubMed     Abstract available


  352. YOUNG KG, McGovern AP, Barroso I, Hattersley AT, et al
    HbA(1c) screening for the diagnosis of diabetes. Reply to Broz J, Brabec M, Krollova P et al [letter].
    Diabetologia. 2023 Jun 5. doi: 10.1007/s00125-023-05939.
    PubMed    


  353. TURK D, Scherer N, Selzer D, Dings C, et al
    Significant impact of time-of-day variation on metformin pharmacokinetics.
    Diabetologia. 2023;66:1024-1034.
    PubMed     Abstract available


  354. VANDERKRUK B, Maeshima N, Pasula DJ, An M, et al
    Methylation of histone H3 lysine 4 is required for maintenance of beta cell function in adult mice.
    Diabetologia. 2023;66:1097-1115.
    PubMed     Abstract available


  355. BLOND MB, Faerch K, Herder C, Ziegler D, et al
    The prediabetes conundrum: striking the balance between risk and resources.
    Diabetologia. 2023;66:1016-1023.
    PubMed     Abstract available


  356. ANDERSON EL, Williams DM
    Drug target Mendelian randomisation: are we really instrumenting drug use?
    Diabetologia. 2023;66:1156-1158.
    PubMed    


    May 2023
  357. ZIEGLER AG
    The countdown to type 1 diabetes: when, how and why does the clock start?
    Diabetologia. 2023 May 26. doi: 10.1007/s00125-023-05927.
    PubMed     Abstract available


  358. TERWEE CB, Elders PJM, Blom MT, Beulens JW, et al
    Patient-reported outcomes for people with diabetes: what and how to measure? A narrative review.
    Diabetologia. 2023 May 24. doi: 10.1007/s00125-023-05926.
    PubMed     Abstract available


  359. CARLSSON PO, Espes D, Sisay S, Davies LC, et al
    Umbilical cord-derived mesenchymal stromal cells preserve endogenous insulin production in type 1 diabetes: a Phase I/II randomised double-blind placebo-controlled trial.
    Diabetologia. 2023 May 24. doi: 10.1007/s00125-023-05934.
    PubMed     Abstract available


  360. HU J, Fang M, Pike JR, Lutsey PL, et al
    Prediabetes, intervening diabetes and subsequent risk of dementia: the Atherosclerosis Risk in Communities (ARIC) study.
    Diabetologia. 2023 May 24. doi: 10.1007/s00125-023-05930.
    PubMed     Abstract available


  361. BROZ J, Brabec M, Krollova P, Fackovcova L, et al
    HbA(1c) screening for the diagnosis of diabetes.
    Diabetologia. 2023 May 23. doi: 10.1007/s00125-023-05924.
    PubMed    


  362. YOUNG KG, McGovern AP, Barroso I, Hattersley AT, et al
    Correction to: The impact of population-level HbA(1c) screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis.
    Diabetologia. 2023 May 22. doi: 10.1007/s00125-023-05933.
    PubMed    


  363. SCHLESINGER S, Lang A, Christodoulou N, Linnerz P, et al
    Risk phenotypes of diabetes and association with COVID-19 severity and death: an update of a living systematic review and meta-analysis.
    Diabetologia. 2023 May 19. doi: 10.1007/s00125-023-05928.
    PubMed     Abstract available


  364. JUVINAO-QUINTERO DL, Sharp GC, Sanderson ECM, Relton CL, et al
    Investigating causality in the association between DNA methylation and type 2 diabetes using bidirectional two-sample Mendelian randomisation.
    Diabetologia. 2023 May 19. doi: 10.1007/s00125-023-05914.
    PubMed     Abstract available


  365. YANG Z, Wu Y, Xu L, Zhu Z, et al
    Age at diagnosis modifies associations of type 2 diabetes with cancer incidence and mortality: a retrospective matched-cohort study.
    Diabetologia. 2023 May 13. doi: 10.1007/s00125-023-05920.
    PubMed     Abstract available


  366. HUERTA-CHAGOYA A, Schroeder P, Mandla R, Deutsch AJ, et al
    The power of TOPMed imputation for the discovery of Latino-enriched rare variants associated with type 2 diabetes.
    Diabetologia. 2023 May 6. doi: 10.1007/s00125-023-05912.
    PubMed     Abstract available


  367. LUTTER D, Sachs S, Walter M, Kerege A, et al
    Skeletal muscle and intermuscular adipose tissue gene expression profiling identifies new biomarkers with prognostic significance for insulin resistance progression and intervention response.
    Diabetologia. 2023;66:873-883.
    PubMed     Abstract available


  368. LEE DS, An TH, Kim H, Jung E, et al
    Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice.
    Diabetologia. 2023;66:931-954.
    PubMed     Abstract available


  369. MARZINOTTO I, Pittman DL, Williams AJK, Long AE, et al
    Islet Autoantibody Standardization Program: interlaboratory comparison of insulin autoantibody assay performance in 2018 and 2020 workshops.
    Diabetologia. 2023;66:897-912.
    PubMed     Abstract available


  370. WENG SW, Wu JC, Shen FC, Chang YH, et al
    Chaperonin counteracts diet-induced non-alcoholic fatty liver disease by aiding sirtuin 3 in the control of fatty acid oxidation.
    Diabetologia. 2023;66:913-930.
    PubMed     Abstract available


    April 2023
  371. ELSENBURG LK, Bengtsson J, Rieckmann A, Rod NH, et al
    Childhood adversity and risk of type 2 diabetes in early adulthood: results from a population-wide cohort study of 1.2 million individuals.
    Diabetologia. 2023 Apr 20. doi: 10.1007/s00125-023-05911.
    PubMed     Abstract available


  372. REYNOLDS A
    Evidence-based European recommendations for the dietary management of diabetes.
    Diabetologia. 2023 Apr 17. doi: 10.1007/s00125-023-05894.
    PubMed     Abstract available


  373. KAUTZKY-WILLER A, Leutner M, Harreiter J
    Correction to: Sex differences in type 2 diabetes.
    Diabetologia. 2023 Apr 12. doi: 10.1007/s00125-023-05913.
    PubMed    


  374. LAUGESEN C, Ranjan AG, Schmidt S, Norgaard K, et al
    Pen-administered low-dose dasiglucagon vs usual care for prevention and treatment of non-severe hypoglycaemia in people with type 1 diabetes during free-living conditions: a Phase II, randomised, open-label, two-period crossover trial.
    Diabetologia. 2023 Apr 11. doi: 10.1007/s00125-023-05909.
    PubMed     Abstract available


  375. MCNEILLY AD, Gallagher JR, Evans ML, de Galan BE, et al
    Chronic hyperglycaemia increases the vulnerability of the hippocampus to oxidative damage induced during post-hypoglycaemic hyperglycaemia in a mouse model of chemically induced type 1 diabetes.
    Diabetologia. 2023 Apr 4. doi: 10.1007/s00125-023-05907.
    PubMed     Abstract available


  376. HELLEPUTTE S, Yardley JE, Scott SN, Stautemas J, et al
    Effects of postprandial exercise on blood glucose levels in adults with type 1 diabetes: a review.
    Diabetologia. 2023 Apr 4. doi: 10.1007/s00125-023-05910.
    PubMed     Abstract available


  377. MATTIS KK, Krentz NAJ, Metzendorf C, Abaitua F, et al
    Loss of RREB1 in pancreatic beta cells reduces cellular insulin content and affects endocrine cell gene expression.
    Diabetologia. 2023;66:674-694.
    PubMed     Abstract available


  378. SEPULVEDA E, Jacob P, Poinhos R, Carvalho D, et al
    Changes in attitudes to awareness of hypoglycaemia during a hypoglycaemia awareness restoration programme are associated with avoidance of further severe hypoglycaemia episodes within 24 months: the A2A in HypoCOMPaSS study.
    Diabetologia. 2023;66:631-641.
    PubMed     Abstract available


  379. RADLINGER B, Ress C, Folie S, Salzmann K, et al
    Empagliflozin protects mice against diet-induced obesity, insulin resistance and hepatic steatosis.
    Diabetologia. 2023;66:754-767.
    PubMed     Abstract available


  380. TARIQ M, de Souza AH, Bensellam M, Chae H, et al
    Prolonged culture of human pancreatic islets under glucotoxic conditions changes their acute beta cell calcium and insulin secretion glucose response curves from sigmoid to bell-shaped.
    Diabetologia. 2023;66:709-723.
    PubMed     Abstract available


    March 2023
  381. ROCA-RIVADA A, Marin-Canas S, Colli ML, Vinci C, et al
    Inhibition of the type 1 diabetes candidate gene PTPN2 aggravates TNF-alpha-induced human beta cell dysfunction and death.
    Diabetologia. 2023 Mar 29. doi: 10.1007/s00125-023-05908.
    PubMed     Abstract available


  382. BELTEKY M, Milletich PL, Ahrens AP, Triplett EW, et al
    Infant gut microbiome composition correlated with type 1 diabetes acquisition in the general population: the ABIS study.
    Diabetologia. 2023 Mar 25. doi: 10.1007/s00125-023-05895.
    PubMed     Abstract available


  383. RATTER-RIECK JM, Roden M, Herder C
    Diabetes and climate change: current evidence and implications for people with diabetes, clinicians and policy stakeholders.
    Diabetologia. 2023 Mar 25:1-13. doi: 10.1007/s00125-023-05901.
    PubMed     Abstract available


  384. HENEBERG P
    A large portion of diabetes cases in sub-Saharan African populations with HIV represent drug-induced diabetes.
    Diabetologia. 2023 Mar 23. doi: 10.1007/s00125-023-05904.
    PubMed    


  385. HATANO Y, VanWagner LB, Carnethon MR, Bancks MP, et al
    Racial difference in the association between non-alcoholic fatty liver disease and incident type 2 diabetes: findings from the CARDIA study.
    Diabetologia. 2023 Mar 21. doi: 10.1007/s00125-023-05903.
    PubMed     Abstract available


  386. LLOYD M, Morton J, Teede H, Marquina C, et al
    Long-term cost-effectiveness of implementing a lifestyle intervention during pregnancy to reduce the incidence of gestational diabetes and type 2 diabetes.
    Diabetologia. 2023 Mar 18. doi: 10.1007/s00125-023-05897.
    PubMed     Abstract available


  387. LI X, Yang Y, Li Z, Wang Y, et al
    Deficiency of WTAP in islet beta cells results in beta cell failure and diabetes in mice.
    Diabetologia. 2023 Mar 15. doi: 10.1007/s00125-023-05900.
    PubMed     Abstract available


  388. REYNOLDS EL, Watanabe M, Banerjee M, Chant E, et al
    The effect of surgical weight loss on diabetes complications in individuals with class II/III obesity.
    Diabetologia. 2023 Mar 14:1-16. doi: 10.1007/s00125-023-05899.
    PubMed     Abstract available


  389. XIAO Y, Wang Y, Ryu J, Liu W, et al
    Upregulated TGF-beta1 contributes to hyperglycaemia in type 2 diabetes by potentiating glucagon signalling.
    Diabetologia. 2023 Mar 14. doi: 10.1007/s00125-023-05889.
    PubMed     Abstract available


  390. RUDMAN N, Kaur S, Simunovic V, Kifer D, et al
    Integrated glycomics and genetics analyses reveal a potential role for N-glycosylation of plasma proteins and IgGs, as well as the complement system, in the development of type 1 diabetes.
    Diabetologia. 2023 Mar 13. doi: 10.1007/s00125-023-05881.
    PubMed     Abstract available


  391. KAUTZKY-WILLER A, Leutner M, Harreiter J
    Sex differences in type 2 diabetes.
    Diabetologia. 2023 Mar 10. doi: 10.1007/s00125-023-05891.
    PubMed     Abstract available


  392. APAOLAZA PS, Balcacean D, Zapardiel-Gonzalo J, Rodriguez-Calvo T, et al
    The extent and magnitude of islet T cell infiltration as powerful tools to define the progression to type 1 diabetes.
    Diabetologia. 2023 Mar 8. doi: 10.1007/s00125-023-05888.
    PubMed     Abstract available


  393. DRENTHEN LCA, Ajie M, Abbink EJ, Rodwell L, et al
    No insulin degludec dose adjustment required after aerobic exercise for people with type 1 diabetes: the ADREM study.
    Diabetologia. 2023 Mar 7:1-10. doi: 10.1007/s00125-023-05893.
    PubMed     Abstract available


  394. WEDEKIND LE, Mahajan A, Hsueh WC, Chen P, et al
    The utility of a type 2 diabetes polygenic score in addition to clinical variables for prediction of type 2 diabetes incidence in birth, youth and adult cohorts in an Indigenous study population.
    Diabetologia. 2023 Mar 2. doi: 10.1007/s00125-023-05870.
    PubMed     Abstract available


  395. MATHIEU C, Kennedy E, Schrauwen P, Mulder H, et al
    The changing landscape of scientific communication at EASD.
    Diabetologia. 2023;66:413-414.
    PubMed    


  396. DU L, Wang P, Chen H, Zhang Y, et al
    GLP1RAs vs SGLT2is were associated with lower risk of major adverse limb events and similar risks of heart failure hospitalisation and stroke?
    Diabetologia. 2023;66:605-606.
    PubMed    


  397. ARSHI B, Chen J, Ikram MA, Zillikens MC, et al
    Advanced glycation end-products, cardiac function and heart failure in the general population: The Rotterdam Study.
    Diabetologia. 2023;66:472-481.
    PubMed     Abstract available


  398. VAN DER VELDE JHPM, Boone SC, Winters-van Eekelen E, Hesselink MKC, et al
    Timing of physical activity in relation to liver fat content and insulin resistance.
    Diabetologia. 2023;66:461-471.
    PubMed     Abstract available


  399. PIGEYRE M, Gerstein H, Ahlqvist E, Hess S, et al
    Identifying blood biomarkers for type 2 diabetes subtyping: a report from the ORIGIN trial.
    Diabetologia. 2023 Mar 1. doi: 10.1007/s00125-023-05887.
    PubMed     Abstract available


    February 2023
  400. WEI Y, Richardson TG, Zhan Y, Carlsson S, et al
    Childhood adiposity and novel subtypes of adult-onset diabetes: a Mendelian randomisation and genome-wide genetic correlation study.
    Diabetologia. 2023 Feb 27. doi: 10.1007/s00125-023-05883.
    PubMed     Abstract available


  401. DE KLERK JA, Beulens JWJ, Mei H, Bijkerk R, et al
    Altered blood gene expression in the obesity-related type 2 diabetes cluster may be causally involved in lipid metabolism: a Mendelian randomisation study.
    Diabetologia. 2023 Feb 24. doi: 10.1007/s00125-023-05886.
    PubMed     Abstract available


  402. DE RITTER R, Sep SJS, van Greevenbroek MMJ, Kusters YHAM, et al
    Sex differences in body composition in people with prediabetes and type 2 diabetes as compared with people with normal glucose metabolism: the Maastricht Study.
    Diabetologia. 2023 Feb 20. doi: 10.1007/s00125-023-05880.
    PubMed     Abstract available


  403. YUAN S, Merino J, Larsson SC
    Causal factors underlying diabetes risk informed by Mendelian randomisation analysis: evidence, opportunities and challenges.
    Diabetologia. 2023 Feb 14. doi: 10.1007/s00125-023-05879.
    PubMed     Abstract available


  404. FOROUHI NG
    Embracing complexity: making sense of diet, nutrition, obesity and type 2 diabetes.
    Diabetologia. 2023 Feb 14:1-14. doi: 10.1007/s00125-023-05873.
    PubMed     Abstract available


  405. GULLAKSEN S, Vernstrom L, Sorensen SS, Ringgaard S, et al
    Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial.
    Diabetologia. 2023 Feb 6. doi: 10.1007/s00125-023-05876.
    PubMed     Abstract available


  406. MUTIE PM, Pomares-Milan H, Atabaki-Pasdar N, Coral D, et al
    Investigating the causal relationships between excess adiposity and cardiometabolic health in men and women.
    Diabetologia. 2023;66:321-335.
    PubMed     Abstract available


    January 2023
  407. LAFERRERE B
    Determination of autoantibodies in type 2 diabetes: one simple way to improve classification. Reply by Laferrere to Ludvigsson J [letter].
    Diabetologia. 2023 Jan 31. doi: 10.1007/s00125-023-05871.
    PubMed    


  408. DE VRIES SAG, Verheugt CL, Mul D, Nieuwdorp M, et al
    Do sex differences in paediatric type 1 diabetes care exist? A systematic review.
    Diabetologia. 2023 Jan 26. doi: 10.1007/s00125-022-05866.
    PubMed     Abstract available


  409. SAADANE A, Veenstra AA, Minns MS, Tang J, et al
    CCR2-positive monocytes contribute to the pathogenesis of early diabetic retinopathy in mice.
    Diabetologia. 2023 Jan 26. doi: 10.1007/s00125-022-05860.
    PubMed     Abstract available


  410. CARRERA P, Marzinotto I, Bonfanti R, Massimino L, et al
    Genetic determinants of type 1 diabetes in individuals with weak evidence of islet autoimmunity at disease onset.
    Diabetologia. 2023 Jan 24. doi: 10.1007/s00125-022-05865.
    PubMed     Abstract available


  411. GOEDECKE JH, Pheiffer C, Mendham AE
    Environmental exposures are important for type 2 diabetes pathophysiology in sub-Saharan African populations. Reply to Christensen D, Hjort L, Mpagama S et al [letter].
    Diabetologia. 2023 Jan 24. doi: 10.1007/s00125-022-05859.
    PubMed    


  412. LEAN MEJ, Taylor R, Sattar N
    Determination of autoantibodies in type 2 diabetes: one simple way to improve classification. Reply by Lean et al to Ludvigsson J [letter].
    Diabetologia. 2023 Jan 24:1-2. doi: 10.1007/s00125-022-05863.
    PubMed    


  413. LING S, Zaccardi F, Issa E, Davies MJ, et al
    Inequalities in cancer mortality trends in people with type 2 diabetes: 20 year population-based study in England.
    Diabetologia. 2023 Jan 24. doi: 10.1007/s00125-022-05854.
    PubMed     Abstract available


  414. CHRISTENSEN DL, Hjort L, Mpagama SG, Ramaiya KL, et al
    Environmental exposures are important for type 2 diabetes pathophysiology in sub-Saharan African populations.
    Diabetologia. 2023 Jan 19. doi: 10.1007/s00125-022-05867.
    PubMed    


  415. HARE MJL, Maple-Brown LJ, Shaw JE, Boyle JA, et al
    Risk of kidney disease following a pregnancy complicated by diabetes: a longitudinal, population-based data-linkage study among Aboriginal women in the Northern Territory, Australia.
    Diabetologia. 2023 Jan 18. doi: 10.1007/s00125-023-05868.
    PubMed     Abstract available


  416. ROSENGREN A, Dikaiou P
    Cardiovascular outcomes in type 1 and type 2 diabetes.
    Diabetologia. 2023 Jan 14:1-13. doi: 10.1007/s00125-022-05857.
    PubMed     Abstract available


  417. THORIUS IH, Husemoen LLN, Nordsborg RB, Alibegovic AC, et al
    Congenital malformations among offspring of women with type 1 diabetes who use insulin pumps: a prospective cohort study.
    Diabetologia. 2023 Jan 14. doi: 10.1007/s00125-022-05864.
    PubMed     Abstract available


  418. LAFONTAINE N, Jolley J, Kyi M, King S, et al
    Prospective randomised placebo-controlled trial assessing the efficacy of silver dressings to enhance healing of acute diabetes-related foot ulcers.
    Diabetologia. 2023 Jan 11. doi: 10.1007/s00125-022-05855.
    PubMed     Abstract available


  419. LUDVIGSSON J
    Determination of autoantibodies in type 2 diabetes: one simple way to improve classification.
    Diabetologia. 2023 Jan 11. doi: 10.1007/s00125-022-05858.
    PubMed     Abstract available


  420. LUPSA BC, Kibbey RG, Inzucchi SE
    Ketones: the double-edged sword of SGLT2 inhibitors?
    Diabetologia. 2023;66:23-32.
    PubMed     Abstract available


  421. ILIODROMITI S, McLaren J, Ghouri N, Miller MR, et al
    Liver, visceral and subcutaneous fat in men and women of South Asian and white European descent: a systematic review and meta-analysis of new and published data.
    Diabetologia. 2023;66:44-56.
    PubMed     Abstract available


  422. MENDHAM AE, Micklesfield LK, Karpe F, Kengne AP, et al
    Targeted proteomics identifies potential biomarkers of dysglycaemia, beta cell function and insulin sensitivity in Black African men and women.
    Diabetologia. 2023;66:174-189.
    PubMed     Abstract available


    December 2022
  423. PENZENSTADLER J, Earp JC, Wood Heickman LK, Pluchino K, et al
    Utility of islet autoantibodies as enrichment biomarkers in type 1 diabetes clinical studies: a viewpoint from the FDA.
    Diabetologia. 2022 Dec 21. doi: 10.1007/s00125-022-05853.
    PubMed    


  424. KIM H, Westerman KE, Smith K, Chiou J, et al
    High-throughput genetic clustering of type 2 diabetes loci reveals heterogeneous mechanistic pathways of metabolic disease.
    Diabetologia. 2022 Dec 20. doi: 10.1007/s00125-022-05848.
    PubMed     Abstract available


  425. LAZZARINI PA, Cramb SM, Golledge J, Morton JI, et al
    Global trends in the incidence of hospital admissions for diabetes-related foot disease and amputations: a review of national rates in the 21st century.
    Diabetologia. 2022 Dec 13. doi: 10.1007/s00125-022-05845.
    PubMed     Abstract available


  426. BOLDISON J, Hopkinson JR, Davies J, Pearson JA, et al
    Gene expression profiling in NOD mice reveals that B cells are highly educated by the pancreatic environment during autoimmune diabetes.
    Diabetologia. 2022 Dec 12. doi: 10.1007/s00125-022-05839.
    PubMed     Abstract available


  427. MAALMI H, Strom A, Petrera A, Hauck SM, et al
    Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy.
    Diabetologia. 2022 Dec 6. doi: 10.1007/s00125-022-05846.
    PubMed     Abstract available


  428. FERRANNINI E, Mari A, Monaco GSF, Skyler JS, et al
    The effect of age on longitudinal measures of beta cell function and insulin sensitivity during the progression of early stage type 1 diabetes.
    Diabetologia. 2022 Dec 2. doi: 10.1007/s00125-022-05836.
    PubMed     Abstract available


  429. SCHOONEJANS JM, Blackmore HL, Ashmore TJ, Pantaleao LC, et al
    Sex-specific effects of maternal metformin intervention during glucose-intolerant obese pregnancy on body composition and metabolic health in aged mouse offspring.
    Diabetologia. 2022;65:2132-2145.
    PubMed     Abstract available


  430. MASSARA P, Zurbau A, Glenn AJ, Chiavaroli L, et al
    Nordic dietary patterns and cardiometabolic outcomes: a systematic review and meta-analysis of prospective cohort studies and randomised controlled trials.
    Diabetologia. 2022;65:2011-2031.
    PubMed     Abstract available


    November 2022
  431. MISTRY S, Gouripeddi R, Raman V, Facelli JC, et al
    Stratifying risk for onset of type 1 diabetes using islet autoantibody trajectory clustering.
    Diabetologia. 2022 Nov 30. doi: 10.1007/s00125-022-05843.
    PubMed     Abstract available


  432. MATHIEU C, Del Prato S
    Women in diabetes research: we can do better. Reply to Bonnefond A [letter].
    Diabetologia. 2022 Nov 29. doi: 10.1007/s00125-022-05840.
    PubMed    


  433. BONNEFOND A
    Women in diabetes research: we can do better.
    Diabetologia. 2022 Nov 26. doi: 10.1007/s00125-022-05825.
    PubMed    


  434. KHUNTI K, Valabhji J, Misra S
    Diabetes and the COVID-19 pandemic.
    Diabetologia. 2022 Nov 23. doi: 10.1007/s00125-022-05833.
    PubMed     Abstract available


  435. HARSUNEN M, Kettunen JLT, Harkonen T, Dwivedi O, et al
    Identification of monogenic variants in more than ten per cent of children without type 1 diabetes-related autoantibodies at diagnosis in the Finnish Pediatric Diabetes Register.
    Diabetologia. 2022 Nov 23. doi: 10.1007/s00125-022-05834.
    PubMed     Abstract available


  436. YOUNG KG, McGovern AP, Barroso I, Hattersley AT, et al
    The impact of population-level HbA(1c) screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis.
    Diabetologia. 2022 Nov 22. doi: 10.1007/s00125-022-05824.
    PubMed     Abstract available


  437. HVID H, Brand CL, Hummelshoj T, Jensen S, et al
    Preclinical exploration of combined glucagon inhibition and liver-preferential insulin for treatment of diabetes using in vitro assays and rat and mouse models.
    Diabetologia. 2022 Nov 21. doi: 10.1007/s00125-022-05828.
    PubMed     Abstract available


  438. MORTON JI, Marquina C, Shaw JE, Liew D, et al
    Projecting the incidence and costs of major cardiovascular and kidney complications of type 2 diabetes with widespread SGLT2i and GLP-1 RA use: a cost-effectiveness analysis.
    Diabetologia. 2022 Nov 21. doi: 10.1007/s00125-022-05832.
    PubMed     Abstract available


  439. COOMANS DE BRACHENE A, Scoubeau C, Musuaya AE, Costa-Junior JM, et al
    Exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes.
    Diabetologia. 2022 Nov 19:1-11. doi: 10.1007/s00125-022-05837.
    PubMed     Abstract available


  440. MATHIEU C, Soderberg J, Del Prato S, Felton AM, et al
    The European Diabetes Forum (EUDF): a forum for turning the tide on diabetes in Europe.
    Diabetologia. 2022 Nov 17. pii: 10.1007/s00125-022-05831.
    PubMed    


  441. JANSEN TJP, Brom M, Boss M, Buitinga M, et al
    Importance of beta cell mass for glycaemic control in people with type 1 diabetes.
    Diabetologia. 2022 Nov 17. pii: 10.1007/s00125-022-05830.
    PubMed     Abstract available


  442. ZHENG R, Xin Z, Li M, Wang T, et al
    Outdoor light at night in relation to glucose homoeostasis and diabetes in Chinese adults: a national and cross-sectional study of 98,658 participants from 162 study sites.
    Diabetologia. 2022 Nov 14. pii: 10.1007/s00125-022-05819.
    PubMed     Abstract available


  443. THOMAS NJ, Walkey HC, Kaur A, Misra S, et al
    The relationship between islet autoantibody status and the genetic risk of type 1 diabetes in adult-onset type 1 diabetes.
    Diabetologia. 2022 Nov 10. pii: 10.1007/s00125-022-05823.
    PubMed     Abstract available


  444. DAL CANTO E, Elders PJM, van der Heijden AA, van Ballegooijen AJ, et al
    Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort.
    Diabetologia. 2022 Nov 8. pii: 10.1007/s00125-022-05826.
    PubMed     Abstract available


  445. CUI X, Feng J, Wei T, Zhang L, et al
    Pancreatic alpha cell glucagon-liver FGF21 axis regulates beta cell regeneration in a mouse model of type 2 diabetes.
    Diabetologia. 2022 Nov 4. pii: 10.1007/s00125-022-05822.
    PubMed     Abstract available


  446. BONNER C, Saponaro C
    Where to for precision treatment of HNF1A-MODY?
    Diabetologia. 2022;65:1825-1829.
    PubMed    


  447. SPARKS JR, Ghildayal N, Hivert MF, Redman LM, et al
    Lifestyle interventions in pregnancy targeting GDM prevention: looking ahead to precision medicine.
    Diabetologia. 2022;65:1814-1824.
    PubMed     Abstract available


    October 2022
  448. DESOYE G, Ringholm L, Damm P, Mathiesen ER, et al
    Secular trend for increasing birthweight in offspring of pregnant women with type 1 diabetes: is improved placentation the reason?
    Diabetologia. 2022 Oct 26. pii: 10.1007/s00125-022-05820.
    PubMed     Abstract available


  449. REDONDO MJ, Richardson SJ, Perry D, Minard CG, et al
    Milder loss of insulin-containing islets in individuals with type 1 diabetes and type 2 diabetes-associated TCF7L2 genetic variants.
    Diabetologia. 2022 Oct 25. pii: 10.1007/s00125-022-05818.
    PubMed     Abstract available


  450. BRUSCO N, Sebastiani G, Di Giuseppe G, Licata G, et al
    Intra-islet insulin synthesis defects are associated with endoplasmic reticulum stress and loss of beta cell identity in human diabetes.
    Diabetologia. 2022 Oct 25. pii: 10.1007/s00125-022-05814.
    PubMed     Abstract available


  451. ZHU H, Leung SW
    MicroRNA biomarkers of type 2 diabetes: evidence synthesis from meta-analyses and pathway modelling.
    Diabetologia. 2022 Oct 21. pii: 10.1007/s00125-022-05809.
    PubMed     Abstract available


  452. WAERNBAUM I, Lind T, Mollsten A, Dahlquist G, et al
    The incidence of childhood-onset type 1 diabetes, time trends and association with the population composition in Sweden: a 40 year follow-up.
    Diabetologia. 2022 Oct 20. pii: 10.1007/s00125-022-05816.
    PubMed     Abstract available


  453. ZHAO XP, Chang SY, Pang Y, Liao MC, et al
    Hedgehog interacting protein activates sodium-glucose cotransporter 2 expression and promotes renal tubular epithelial cell senescence in a mouse model of type 1 diabetes.
    Diabetologia. 2022 Oct 19. pii: 10.1007/s00125-022-05810.
    PubMed     Abstract available


  454. LO DF, Zia H, Zia T, Visaria A, et al
    Investigating mortality in the association between depression and diabetes.
    Diabetologia. 2022 Oct 12. pii: 10.1007/s00125-022-05807.
    PubMed    


  455. STALBOW LA, Preuss MH, Smit RAJ, Chami N, et al
    The contribution of functional HNF1A variants and polygenic susceptibility to risk of type 2 diabetes in ancestrally diverse populations.
    Diabetologia. 2022 Oct 11. pii: 10.1007/s00125-022-05806.
    PubMed     Abstract available


  456. STROLLO R, Vinci C, Man YKS, Bruzzaniti S, et al
    Autoantibody and T cell responses to oxidative post-translationally modified insulin neoantigenic peptides in type 1 diabetes.
    Diabetologia. 2022 Oct 7. pii: 10.1007/s00125-022-05812.
    PubMed     Abstract available


  457. HERING BJ, Ballou CM, Bellin MD, Payne EH, et al
    Factors associated with favourable 5 year outcomes in islet transplant alone recipients with type 1 diabetes complicated by severe hypoglycaemia in the Collaborative Islet Transplant Registry.
    Diabetologia. 2022 Oct 6. pii: 10.1007/s00125-022-05804.
    PubMed     Abstract available


  458. SHERR JL, Heinemann L, Fleming GA, Bergenstal RM, et al
    Automated insulin delivery: benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association.
    Diabetologia. 2022 Oct 6. pii: 10.1007/s00125-022-05744.
    PubMed     Abstract available


  459. ZHANG YB, Pan XF, Lu Q, Wang YX, et al
    Correction to: Associations of combined healthy lifestyles with cancer morbidity and mortality among individuals with diabetes: results from five cohort studies in the USA, the UK and China.
    Diabetologia. 2022 Oct 5. pii: 10.1007/s00125-022-05802.
    PubMed    


  460. NG K, Anand V, Stavropoulos H, Veijola R, et al
    Quantifying the utility of islet autoantibody levels in the prediction of type 1 diabetes in children.
    Diabetologia. 2022 Oct 5. pii: 10.1007/s00125-022-05799.
    PubMed     Abstract available


  461. WEISS A, Zapardiel-Gonzalo J, Voss F, Jolink M, et al
    Correction to: Progression likelihood score identifies substages of presymptomatic type 1 diabetes in childhood public health screening.
    Diabetologia. 2022 Oct 4. pii: 10.1007/s00125-022-05798.
    PubMed    


  462. JALLEH RJ, Jones KL, Rayner CK, Marathe CS, et al
    Normal and disordered gastric emptying in diabetes: recent insights into (patho)physiology, management and impact on glycaemic control.
    Diabetologia. 2022 Oct 4. pii: 10.1007/s00125-022-05796.
    PubMed     Abstract available


  463. STEFFEN BT, Tang W, Lutsey PL, Demmer RT, et al
    Proteomic analysis of diabetes genetic risk scores identifies complement C2 and neuropilin-2 as predictors of type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) Study.
    Diabetologia. 2022 Oct 4. pii: 10.1007/s00125-022-05801.
    PubMed     Abstract available


  464. CASTILLO JJ, Aplin AC, Hackney DJ, Hogan MF, et al
    Islet amyloid polypeptide aggregation exerts cytotoxic and proinflammatory effects on the islet vasculature in mice.
    Diabetologia. 2022;65:1687-1700.
    PubMed     Abstract available


    September 2022
  465. SARABHAI T, Mastrototaro L, Kahl S, Bonhof GJ, et al
    Hyperbaric oxygen rapidly improves tissue-specific insulin sensitivity and mitochondrial capacity in humans with type 2 diabetes: a randomised placebo-controlled crossover trial.
    Diabetologia. 2022 Sep 30. pii: 10.1007/s00125-022-05797.
    PubMed     Abstract available


  466. HENRIKSEN RE, Nilsen RM, Strandberg RB
    Loneliness increases the risk of type 2 diabetes: a 20 year follow-up - results from the HUNT study.
    Diabetologia. 2022 Sep 28. pii: 10.1007/s00125-022-05791.
    PubMed     Abstract available


  467. GOEDECKE JH, Mendham AE
    Pathophysiology of type 2 diabetes in sub-Saharan Africans.
    Diabetologia. 2022 Sep 27. pii: 10.1007/s00125-022-05795.
    PubMed     Abstract available


  468. DAVIES MJ, Aroda VR, Collins BS, Gabbay RA, et al
    Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
    Diabetologia. 2022 Sep 24. pii: 10.1007/s00125-022-05787.
    PubMed     Abstract available


  469. SIMONS PIHG, Valkenburg O, van de Waarenburg MPH, van Greevenbroek MMJ, et al
    Serum sex hormone-binding globulin is a mediator of the association between intrahepatic lipid content and type 2 diabetes: the Maastricht Study.
    Diabetologia. 2022 Sep 17. pii: 10.1007/s00125-022-05790.
    PubMed     Abstract available


  470. ZHANG YB, Pan XF, Lu Q, Wang YX, et al
    Associations of combined healthy lifestyles with cancer morbidity and mortality among individuals with diabetes: results from five cohort studies in the USA, the UK and China.
    Diabetologia. 2022 Sep 14. pii: 10.1007/s00125-022-05754.
    PubMed     Abstract available


  471. KOBO O, Van Spall HGC, Mamas MA
    Urban-rural disparities in diabetes-related mortality in the USA 1999-2019.
    Diabetologia. 2022 Sep 10. pii: 10.1007/s00125-022-05785.
    PubMed     Abstract available


  472. KORDONOURI O, Cuthbertson D, Belteky M, Aschemeier-Fuchs B, et al
    Infections in the first year of life and development of beta cell autoimmunity and clinical type 1 diabetes in high-risk individuals: the TRIGR cohort.
    Diabetologia. 2022 Sep 9. pii: 10.1007/s00125-022-05786.
    PubMed     Abstract available


  473. WANG J, Liu JJ, Gurung RL, Liu S, et al
    Correction: Clinical variable-based cluster analysis identifies novel subgroups with a distinct genetic signature, lipidomic pattern and cardio-renal risks in Asian patients with recent-onset type 2 diabetes.
    Diabetologia. 2022 Sep 7. pii: 10.1007/s00125-022-05783.
    PubMed    


  474. DIBATO J, Montvida O, Ling J, Koye D, et al
    Temporal trends in the prevalence and incidence of depression and the interplay of comorbidities in patients with young- and usual-onset type 2 diabetes from the USA and the UK.
    Diabetologia. 2022 Sep 5. pii: 10.1007/s00125-022-05764.
    PubMed     Abstract available


  475. PAPAIOANNOU TG, Sanoudou D, Tsioufis C
    Continuous glucose monitoring and hypoglycaemia events: unmet needs.
    Diabetologia. 2022;65:1569-1570.
    PubMed    


    August 2022
  476. WEISS A, Zapardiel-Gonzalo J, Voss F, Jolink M, et al
    Progression likelihood score identifies substages of presymptomatic type 1 diabetes in childhood public health screening.
    Diabetologia. 2022 Aug 27. pii: 10.1007/s00125-022-05780.
    PubMed     Abstract available


  477. GRIFFIN S
    Diabetes precision medicine: plenty of potential, pitfalls and perils but not yet ready for prime time.
    Diabetologia. 2022 Aug 24. pii: 10.1007/s00125-022-05782.
    PubMed     Abstract available


  478. KROOK A, Mulder H
    Pinpointing precision medicine for diabetes mellitus.
    Diabetologia. 2022 Aug 23. pii: 10.1007/s00125-022-05777.
    PubMed    


  479. CARR ALJ, Evans-Molina C, Oram RA
    Precision medicine in type 1 diabetes.
    Diabetologia. 2022 Aug 22. pii: 10.1007/s00125-022-05778.
    PubMed     Abstract available


  480. YARDLEY JE
    Reassessing the evidence: prandial state dictates glycaemic responses to exercise in individuals with type 1 diabetes to a greater extent than intensity.
    Diabetologia. 2022 Aug 18. pii: 10.1007/s00125-022-05781.
    PubMed     Abstract available


  481. KROGVOLD L, Genoni A, Puggioni A, Campani D, et al
    Live enteroviruses, but not other viruses, detected in human pancreas at the onset of type 1 diabetes in the DiViD study.
    Diabetologia. 2022 Aug 12. pii: 10.1007/s00125-022-05779.
    PubMed     Abstract available


  482. DEUTSCH AJ, Ahlqvist E, Udler MS
    Phenotypic and genetic classification of diabetes.
    Diabetologia. 2022 Aug 12. pii: 10.1007/s00125-022-05769.
    PubMed     Abstract available


  483. SANCHEZ-SORIANO C, Pearson ER, Reynolds RM
    Associations between parental type 2 diabetes risk and offspring birthweight and placental weight: a survival analysis using the Walker cohort.
    Diabetologia. 2022 Aug 11. pii: 10.1007/s00125-022-05776.
    PubMed     Abstract available


  484. LIN DS, Yu AL, Lo HY, Lien CW, et al
    Major adverse cardiovascular and limb events in people with diabetes treated with GLP-1 receptor agonists vs SGLT2 inhibitors.
    Diabetologia. 2022 Aug 9. pii: 10.1007/s00125-022-05772.
    PubMed     Abstract available


  485. ZHANG X, Ren H, Zhao C, Shi Z, et al
    Metagenomic analysis reveals crosstalk between gut microbiota and glucose-lowering drugs targeting the gastrointestinal tract in Chinese patients with type 2 diabetes: a 6 month, two-arm randomised trial.
    Diabetologia. 2022 Aug 5. pii: 10.1007/s00125-022-05768.
    PubMed     Abstract available


  486. MARILLY E, Cottin J, Cabrera N, Cornu C, et al
    SGLT2 inhibitors in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials balancing their risks and benefits.
    Diabetologia. 2022 Aug 4. pii: 10.1007/s00125-022-05773.
    PubMed     Abstract available


  487. BAO X, Xu B, Muhammad IF, Nilsson PM, et al
    Plasma prostasin: a novel risk marker for incidence of diabetes and cancer mortality.
    Diabetologia. 2022 Aug 4. pii: 10.1007/s00125-022-05771.
    PubMed     Abstract available



  488. 58(th) EASD Annual Meeting of the European Association for the Study of Diabetes : Stockholm, Sweden, 19 - 23 September 2022.
    Diabetologia. 2022 Aug 3. pii: 10.1007/s00125-022-05755.
    PubMed    


  489. PORTILLO JC, Yu JS, Vos S, Bapputty R, et al
    Disruption of retinal inflammation and the development of diabetic retinopathy in mice by a CD40-derived peptide or mutation of CD40 in Muller cells.
    Diabetologia. 2022 Aug 3. pii: 10.1007/s00125-022-05775.
    PubMed     Abstract available


  490. WAREHAM NJ
    Personalised prevention of type 2 diabetes.
    Diabetologia. 2022 Aug 2. pii: 10.1007/s00125-022-05774.
    PubMed     Abstract available


  491. MERINO B, Casanueva-Alvarez E, Quesada I, Gonzalez-Casimiro CM, et al
    Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation.
    Diabetologia. 2022;65:1375-1389.
    PubMed     Abstract available


  492. NGARA M, Wierup N
    Lessons from single-cell RNA sequencing of human islets.
    Diabetologia. 2022;65:1241-1250.
    PubMed     Abstract available


    July 2022
  493. VERGES B
    Intestinal lipid absorption and transport in type 2 diabetes.
    Diabetologia. 2022 Jul 30. pii: 10.1007/s00125-022-05765.
    PubMed     Abstract available


  494. ERIKSSON JW, Eliasson B, Bennet L, Sundstrom J, et al
    Registry-based randomised clinical trials: a remedy for evidence-based diabetes care?
    Diabetologia. 2022 Jul 29. pii: 10.1007/s00125-022-05762.
    PubMed     Abstract available


  495. EDSTORP J, Wei Y, Ahlqvist E, Alfredsson L, et al
    Smoking, use of smokeless tobacco, HLA genotypes and incidence of latent autoimmune diabetes in adults.
    Diabetologia. 2022 Jul 28. pii: 10.1007/s00125-022-05763.
    PubMed     Abstract available


  496. ANDRIESSEN C, Fealy CE, Veelen A, van Beek SMM, et al
    Three weeks of time-restricted eating improves glucose homeostasis in adults with type 2 diabetes but does not improve insulin sensitivity: a randomised crossover trial.
    Diabetologia. 2022 Jul 25. pii: 10.1007/s00125-022-05752.
    PubMed     Abstract available


  497. SIOOFY-KHOJINE AB, Richardson SJ, Locke JM, Oikarinen S, et al
    Detection of enterovirus RNA in peripheral blood mononuclear cells correlates with the presence of the predisposing allele of the type 1 diabetes risk gene IFIH1 and with disease stage.
    Diabetologia. 2022 Jul 22. pii: 10.1007/s00125-022-05753.
    PubMed     Abstract available


  498. KARPEN SR, Dunne JL, Frohnert BI, Marinac M, et al
    Consortium-based approach to receiving an EMA qualification opinion on the use of islet autoantibodies as enrichment biomarkers in type 1 diabetes clinical studies.
    Diabetologia. 2022 Jul 22. pii: 10.1007/s00125-022-05751.
    PubMed     Abstract available


  499. WANG W, Luo J, Willems van Dijk K, Hagg S, et al
    Assessment of the bi-directional relationship between blood mitochondrial DNA copy number and type 2 diabetes mellitus: a multivariable-adjusted regression and Mendelian randomisation study.
    Diabetologia. 2022 Jul 22. pii: 10.1007/s00125-022-05759.
    PubMed     Abstract available


  500. VERHULST CEM, Fabricius TW, Teerenstra S, Kristensen PL, et al
    Glycaemic thresholds for counterregulatory hormone and symptom responses to hypoglycaemia in people with and without type 1 diabetes: a systematic review.
    Diabetologia. 2022 Jul 22. pii: 10.1007/s00125-022-05749.
    PubMed     Abstract available


  501. ZHAO Y, Li Y, Zhuang Z, Song Z, et al
    Associations of polysocial risk score, lifestyle and genetic factors with incident type 2 diabetes: a prospective cohort study.
    Diabetologia. 2022 Jul 21. pii: 10.1007/s00125-022-05761.
    PubMed     Abstract available


  502. LESSIEUR EM, Liu H, Saadane A, Du Y, et al
    ICAM-1 on the luminal surface of endothelial cells is induced to a greater extent in mouse retina than in other tissues in diabetes.
    Diabetologia. 2022 Jul 19. pii: 10.1007/s00125-022-05719.
    PubMed     Abstract available


  503. TAPP RJ, Owen CG, Barman SA, Strachan DP, et al
    Retinal microvascular associations with cardiometabolic risk factors differ by diabetes status: results from the UK Biobank.
    Diabetologia. 2022 Jul 19. pii: 10.1007/s00125-022-05745.
    PubMed     Abstract available


  504. PARK SK, Wang X, Karvonen-Gutierrez CA
    Potential confounders in the association between per- and polyfluoroalkyl substance exposure and diabetes. Reply to Harada KH, Harada Sassa M [letter].
    Diabetologia. 2022 Jul 18. pii: 10.1007/s00125-022-05757.
    PubMed    


  505. HARADA KH, Harada Sassa M
    Potential confounders in the association between per- and polyfluoroalkyl substance exposure and diabetes.
    Diabetologia. 2022 Jul 16. pii: 10.1007/s00125-022-05758.
    PubMed    


  506. ZOU X, Huang Q, Luo Y, Ren Q, et al
    The efficacy of canagliflozin in diabetes subgroups stratified by data-driven clustering or a supervised machine learning method: a post hoc analysis of canagliflozin clinical trial data.
    Diabetologia. 2022 Jul 8. pii: 10.1007/s00125-022-05748.
    PubMed     Abstract available


  507. HABIBE JJ, Clemente-Olivo MP, Scheithauer TPM, Rampanelli E, et al
    Glucose-mediated insulin secretion is improved in FHL2-deficient mice and elevated FHL2 expression in humans is associated with type 2 diabetes.
    Diabetologia. 2022 Jul 8. pii: 10.1007/s00125-022-05750.
    PubMed     Abstract available


  508. WAIJER SW, Vart P, Cherney DZI, Chertow GM, et al
    Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial.
    Diabetologia. 2022;65:1085-1097.
    PubMed     Abstract available


  509. MEYHOFER S, Dembinski K, Schultes B, Born J, et al
    Sleep deprivation prevents counterregulatory adaptation to recurrent hypoglycaemia.
    Diabetologia. 2022;65:1212-1221.
    PubMed     Abstract available


    June 2022
  510. LIU Q, Tang B, Zhu Z, Kraft P, et al
    A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome.
    Diabetologia. 2022 Jun 30. pii: 10.1007/s00125-022-05746.
    PubMed     Abstract available


  511. HUANG X, Qiu Y, Gao Y, Zhou R, et al
    Gut microbiota mediate melatonin signalling in association with type 2 diabetes.
    Diabetologia. 2022 Jun 30. pii: 10.1007/s00125-022-05747.
    PubMed     Abstract available


  512. WANG J, Liu JJ, Gurung RL, Liu S, et al
    Clinical variable-based cluster analysis identifies novel subgroups with a distinct genetic signature, lipidomic pattern and cardio-renal risks in Asian patients with recent-onset type 2 diabetes.
    Diabetologia. 2022 Jun 28. pii: 10.1007/s00125-022-05741.
    PubMed     Abstract available


  513. SANDHOLM N, Cole JB, Nair V, Sheng X, et al
    Genome-wide meta-analysis and omics integration identifies novel genes associated with diabetic kidney disease.
    Diabetologia. 2022 Jun 28. pii: 10.1007/s00125-022-05735.
    PubMed     Abstract available


  514. FLOREZ JC, Pearson ER
    A roadmap to achieve pharmacological precision medicine in diabetes.
    Diabetologia. 2022 Jun 24. pii: 10.1007/s00125-022-05732.
    PubMed     Abstract available


  515. KREMERS SHM, Wild SH, Elders PJM, Beulens JWJ, et al
    The role of mental disorders in precision medicine for diabetes: a narrative review.
    Diabetologia. 2022 Jun 22. pii: 10.1007/s00125-022-05738.
    PubMed     Abstract available


  516. SCHIBORN C, Schulze MB
    Precision prognostics for the development of complications in diabetes.
    Diabetologia. 2022 Jun 21. pii: 10.1007/s00125-022-05731.
    PubMed     Abstract available


  517. WANG H, Gou W, Su C, Du W, et al
    Correction to: Association of gut microbiota with glycaemic traits and incident type 2 diabetes, and modulation by habitual diet: a population-based longitudinal cohort study in Chinese adults.
    Diabetologia. 2022 Jun 20. pii: 10.1007/s00125-022-05737.
    PubMed    


  518. LAAJALA E, Kalim UU, Gronroos T, Rasool O, et al
    Umbilical cord blood DNA methylation in children who later develop type 1 diabetes.
    Diabetologia. 2022 Jun 18. pii: 10.1007/s00125-022-05726.
    PubMed     Abstract available


  519. LI G, Zhang J, Van Spall HGC, Douglas PS, et al
    Exploring ethnic representativeness in diabetes clinical trial enrolment from 2000 to 2020: a chronological survey.
    Diabetologia. 2022 Jun 16. pii: 10.1007/s00125-022-05736.
    PubMed     Abstract available


  520. VIGILI DE KREUTZENBERG S, Giannella A, Ceolotto G, Faggin E, et al
    A miR-125/Sirtuin-7 pathway drives the pro-calcific potential of myeloid cells in diabetic vascular disease.
    Diabetologia. 2022 Jun 16. pii: 10.1007/s00125-022-05733.
    PubMed     Abstract available


  521. CARIOU B, Wargny M, Boureau AS, Smati S, et al
    Impact of diabetes on COVID-19 prognosis beyond comorbidity burden: the CORONADO initiative.
    Diabetologia. 2022 Jun 15. pii: 10.1007/s00125-022-05734.
    PubMed     Abstract available


  522. BAILEY J, Coucha M, Bolduc DR, Burnett FN, et al
    GLP-1 receptor nitration contributes to loss of brain pericyte function in a mouse model of diabetes.
    Diabetologia. 2022 Jun 10. pii: 10.1007/s00125-022-05730.
    PubMed     Abstract available


  523. ZUCKER I, Zloof Y, Bardugo A, Tsur AM, et al
    Obesity in late adolescence and incident type 1 diabetes in young adulthood.
    Diabetologia. 2022 Jun 5. pii: 10.1007/s00125-022-05722.
    PubMed     Abstract available


  524. NGUYEN-TU MS, Harris J, Martinez-Sanchez A, Chabosseau P, et al
    Opposing effects on regulated insulin secretion of acute vs chronic stimulation of AMP-activated protein kinase.
    Diabetologia. 2022;65:997-1011.
    PubMed     Abstract available


    May 2022
  525. GRAUSLUND J
    Diabetic retinopathy screening in the emerging era of artificial intelligence.
    Diabetologia. 2022 May 31. pii: 10.1007/s00125-022-05727.
    PubMed     Abstract available


  526. RUDMAN N, Kifer D, Kaur S, Simunovic V, et al
    Children at onset of type 1 diabetes show altered N-glycosylation of plasma proteins and IgG.
    Diabetologia. 2022 May 27. pii: 10.1007/s00125-022-05703.
    PubMed     Abstract available


  527. PRIGGE R, Wild SH, Jackson CA
    Depression, diabetes, comorbid depression and diabetes and risk of all-cause and cause-specific mortality: a prospective cohort study.
    Diabetologia. 2022 May 27. pii: 10.1007/s00125-022-05723.
    PubMed     Abstract available


  528. BONNEFOND A, Semple RK
    Achievements, prospects and challenges in precision care for monogenic insulin-deficient and insulin-resistant diabetes.
    Diabetologia. 2022 May 27. pii: 10.1007/s00125-022-05720.
    PubMed     Abstract available


  529. ZHU R, Craciun I, Bernhards-Werge J, Jalo E, et al
    Age- and sex-specific effects of a long-term lifestyle intervention on body weight and cardiometabolic health markers in adults with prediabetes: results from the diabetes prevention study PREVIEW.
    Diabetologia. 2022 May 25. pii: 10.1007/s00125-022-05716.
    PubMed     Abstract available


  530. BRUZZANITI S, Piemonte E, Mozzillo E, Bruzzese D, et al
    High levels of blood circulating immune checkpoint molecules in children with new-onset type 1 diabetes are associated with the risk of developing an additional autoimmune disease.
    Diabetologia. 2022 May 25. pii: 10.1007/s00125-022-05724.
    PubMed     Abstract available


  531. ALSHEHRI Z, Subramanian A, Adderley NJ, Gokhale KM, et al
    Risk of incident obstructive sleep apnoea in patients with type 1 diabetes: a population-based retrospective cohort study.
    Diabetologia. 2022 May 24. pii: 10.1007/s00125-022-05714.
    PubMed     Abstract available


  532. WEI Y, Zhan Y, Lofvenborg JE, Tuomi T, et al
    Birthweight, BMI in adulthood and latent autoimmune diabetes in adults: a Mendelian randomisation study.
    Diabetologia. 2022 May 23. pii: 10.1007/s00125-022-05725.
    PubMed     Abstract available


  533. MERINO J
    Precision nutrition in diabetes: when population-based dietary advice gets personal.
    Diabetologia. 2022 May 20. pii: 10.1007/s00125-022-05721.
    PubMed     Abstract available


  534. PEARSON JA, Ding H, Hu C, Peng J, et al
    IgM-associated gut bacteria in obesity and type 2 diabetes in C57BL/6 mice and humans.
    Diabetologia. 2022 May 19. pii: 10.1007/s00125-022-05711.
    PubMed     Abstract available


  535. LIU J, Bai R, Chai Z, Cooper ME, et al
    Low- and middle-income countries demonstrate rapid growth of type 2 diabetes: an analysis based on Global Burden of Disease 1990-2019 data.
    Diabetologia. 2022 May 19. pii: 10.1007/s00125-022-05713.
    PubMed     Abstract available


  536. KARAGIANNIS T, Avgerinos I, Liakos A, Del Prato S, et al
    Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis.
    Diabetologia. 2022 May 17. pii: 10.1007/s00125-022-05715.
    PubMed     Abstract available


  537. PEREA V, Picon MJ, Megia A, Goya M, et al
    Addition of intermittently scanned continuous glucose monitoring to standard care in a cohort of pregnant women with type 1 diabetes: effect on glycaemic control and pregnancy outcomes.
    Diabetologia. 2022 May 12. pii: 10.1007/s00125-022-05717.
    PubMed     Abstract available


  538. WOELFLE T, Linkohr B, Waterboer T, Thorand B, et al
    Health impact of seven herpesviruses on (pre)diabetes incidence and HbA1c: results from the KORA cohort.
    Diabetologia. 2022 May 11. pii: 10.1007/s00125-022-05704.
    PubMed     Abstract available


  539. KAWADA-HORITANI E, Kita S, Okita T, Nakamura Y, et al
    Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint blockade.
    Diabetologia. 2022 May 5. pii: 10.1007/s00125-022-05708.
    PubMed     Abstract available


  540. CHERNEY DZI, Charbonnel B, Cosentino F, Dagogo-Jack S, et al
    Ertugliflozin, renoprotection and potential confounding by muscle wasting. Reply to Groothof D, Post A, Gans ROB et al [letter].
    Diabetologia. 2022;65:908-911.
    PubMed    


  541. PATARRAO RS, Duarte N, Coelho I, Ward J, et al
    Prediabetes blunts DPP4 genetic control of postprandial glycaemia and insulin secretion.
    Diabetologia. 2022;65:861-871.
    PubMed     Abstract available


  542. STARSKAIA I, Laajala E, Gronroos T, Harkonen T, et al
    Early DNA methylation changes in children developing beta cell autoimmunity at a young age.
    Diabetologia. 2022;65:844-860.
    PubMed     Abstract available


  543. DETTMER R, Niwolik I, Cirksena K, Yoshimoto T, et al
    Proinflammatory cytokines induce rapid, NO-independent apoptosis, expression of chemotactic mediators and interleukin-32 secretion in human pluripotent stem cell-derived beta cells.
    Diabetologia. 2022;65:829-843.
    PubMed     Abstract available


  544. GROOTHOF D, Post A, Gans ROB, Bakker SJL, et al
    Ertugliflozin, renoprotection and potential confounding by muscle wasting.
    Diabetologia. 2022;65:906-907.
    PubMed    


    April 2022
  545. HUVINEN E, Lahti J, Klemetti MM, Bergman PH, et al
    Genetic risk of type 2 diabetes modifies the effects of a lifestyle intervention aimed at the prevention of gestational and postpartum diabetes.
    Diabetologia. 2022 Apr 30. pii: 10.1007/s00125-022-05712.
    PubMed     Abstract available


  546. WYATT RC, Hagopian WA, Roep BO, Patel KA, et al
    Congenital beta cell defects are not associated with markers of islet autoimmunity, even in the context of high genetic risk for type 1 diabetes.
    Diabetologia. 2022 Apr 30. pii: 10.1007/s00125-022-05697.
    PubMed     Abstract available


  547. KAMRATH C, Tittel SR, Dunstheimer D, Frohlich-Reiterer E, et al
    Early vs late histological confirmation of coeliac disease in children with new-onset type 1 diabetes.
    Diabetologia. 2022 Apr 30. pii: 10.1007/s00125-022-05701.
    PubMed     Abstract available


  548. ZHANG J, Chen Z, Parna K, van Zon SKR, et al
    Mediators of the association between educational attainment and type 2 diabetes mellitus: a two-step multivariable Mendelian randomisation study.
    Diabetologia. 2022 Apr 28. pii: 10.1007/s00125-022-05705.
    PubMed     Abstract available


  549. SIDDIQUI MK, Anjana RM, Dawed AY, Martoeau C, et al
    Correction to: Young-onset diabetes in Asian Indians is associated with lower measured and genetically determined beta cell function.
    Diabetologia. 2022 Apr 26. pii: 10.1007/s00125-022-05707.
    PubMed    


  550. SOULIMANE S, Balkau B, Vogtschmidt YD, Toeller M, et al
    Incident cardiovascular disease by clustering of favourable risk factors in type 1 diabetes: the EURODIAB Prospective Complications Study.
    Diabetologia. 2022 Apr 12. pii: 10.1007/s00125-022-05698.
    PubMed     Abstract available


  551. PARK SK, Wang X, Ding N, Karvonen-Gutierrez CA, et al
    Per- and polyfluoroalkyl substances and incident diabetes in midlife women: the Study of Women's Health Across the Nation (SWAN).
    Diabetologia. 2022 Apr 11. pii: 10.1007/s00125-022-05695.
    PubMed     Abstract available


  552. WANG F, Baden MY, Guasch-Ferre M, Wittenbecher C, et al
    Plasma metabolite profiles related to plant-based diets and the risk of type 2 diabetes.
    Diabetologia. 2022 Apr 8. pii: 10.1007/s00125-022-05692.
    PubMed     Abstract available


  553. HERMANNS N, Ehrmann D, Shapira A, Kulzer B, et al
    Coordination of glucose monitoring, self-care behaviour and mental health: achieving precision monitoring in diabetes.
    Diabetologia. 2022 Apr 5. pii: 10.1007/s00125-022-05685.
    PubMed     Abstract available


  554. TIGCHELAAR C, van Zuylen ML, Hulst AH, Preckel B, et al
    Elevated cerebrospinal fluid glucose levels and diabetes mellitus are associated with activation of the neurotoxic polyol pathway.
    Diabetologia. 2022 Apr 5. pii: 10.1007/s00125-022-05693.
    PubMed     Abstract available


  555. THOMSEN MN, Astrup A, Holst JJ, Madsbad S, et al
    Long-term outcomes of dietary carbohydrate restriction for HbA1c reduction in type 2 diabetes mellitus are needed. Reply to Kang J and Ma E [letter].
    Diabetologia. 2022 Apr 1. pii: 10.1007/s00125-022-05689.
    PubMed    


  556. KETTUNEN JLT, Rantala E, Dwivedi OP, Isomaa B, et al
    A multigenerational study on phenotypic consequences of the most common causal variant of HNF1A-MODY.
    Diabetologia. 2022;65:632-643.
    PubMed     Abstract available


    March 2022
  557. CHEN GC, Chai JC, Xing J, Moon JY, et al
    Healthful eating patterns, serum metabolite profile and risk of diabetes in a population-based prospective study of US Hispanics/Latinos.
    Diabetologia. 2022 Mar 31. pii: 10.1007/s00125-022-05690.
    PubMed     Abstract available


  558. KANG J, Ma E
    Long-term outcomes of dietary carbohydrate restriction for HbA1c reduction in type 2 diabetes mellitus are needed.
    Diabetologia. 2022 Mar 31. pii: 10.1007/s00125-022-05688.
    PubMed    


  559. WANG H, Gou W, Su C, Du W, et al
    Association of gut microbiota with glycaemic traits and incident type 2 diabetes, and modulation by habitual diet: a population-based longitudinal cohort study in Chinese adults.
    Diabetologia. 2022 Mar 31. pii: 10.1007/s00125-022-05687.
    PubMed     Abstract available


  560. JACOB P, Potts L, Maclean RH, de Zoysa N, et al
    Characteristics of adults with type 1 diabetes and treatment-resistant problematic hypoglycaemia: a baseline analysis from the HARPdoc RCT.
    Diabetologia. 2022 Mar 24. pii: 10.1007/s00125-022-05679.
    PubMed     Abstract available


  561. CARLTON J, Leaviss J, Pouwer F, Hendrieckx C, et al
    Correction to: The suitability of patient-reported outcome measures used to assess the impact of hypoglycaemia on quality of life in people with diabetes: a systematic review using COSMIN methods.
    Diabetologia. 2022 Mar 23. pii: 10.1007/s00125-022-05668.
    PubMed    


  562. BATISTA TM, Haider N, Kahn CR
    Correction to: Defining the underlying defect in insulin action in type 2 diabetes.
    Diabetologia. 2022 Mar 23. pii: 10.1007/s00125-022-05684.
    PubMed    


  563. LEE K, Chan JY, Liang C, Ip CK, et al
    XBP1 maintains beta cell identity, represses beta-to-alpha cell transdifferentiation and protects against diabetic beta cell failure during metabolic stress in mice.
    Diabetologia. 2022 Mar 22. pii: 10.1007/s00125-022-05669.
    PubMed     Abstract available


  564. RUIZ PLD, Chen L, Morton JI, Salim A, et al
    Mortality trends in type 1 diabetes: a multicountry analysis of six population-based cohorts.
    Diabetologia. 2022 Mar 22. pii: 10.1007/s00125-022-05659.
    PubMed     Abstract available


  565. LING C
    Pharmacoepigenetics in type 2 diabetes: is it clinically relevant?
    Diabetologia. 2022 Mar 21. pii: 10.1007/s00125-022-05681.
    PubMed     Abstract available


  566. MULDER H, Fall T
    The COVID-19 pandemic may be receding but the diabetes pandemic rages on.
    Diabetologia. 2022 Mar 16. pii: 10.1007/s00125-022-05683.
    PubMed    


  567. RATHMANN W, Kuss O, Kostev K
    Incidence of newly diagnosed diabetes after Covid-19.
    Diabetologia. 2022 Mar 16. pii: 10.1007/s00125-022-05670.
    PubMed     Abstract available


  568. DE SOUZA CORDEIRO LM, Bainbridge L, Devisetty N, McDougal DH, et al
    Loss of function of renal Glut2 reverses hyperglycaemia and normalises body weight in mouse models of diabetes and obesity.
    Diabetologia. 2022 Mar 15. pii: 10.1007/s00125-022-05676.
    PubMed     Abstract available


  569. ECHOUFFO-TCHEUGUI JB, Daya N, Ndumele CE, Matsushita K, et al
    Diabetes, GDF-15 and incident heart failure: the atherosclerosis risk in communities study.
    Diabetologia. 2022 Mar 11. pii: 10.1007/s00125-022-05678.
    PubMed     Abstract available


  570. BONHOF GJ, Strom A, Apostolopoulou M, Karusheva Y, et al
    High-intensity interval training for 12 weeks improves cardiovascular autonomic function but not somatosensory nerve function and structure in overweight men with type 2 diabetes.
    Diabetologia. 2022 Mar 11. pii: 10.1007/s00125-022-05674.
    PubMed     Abstract available


  571. SANCHEZ-RANGEL E, Gunawan F, Jiang L, Savoye M, et al
    Reversibility of brain glucose kinetics in type 2 diabetes mellitus.
    Diabetologia. 2022 Mar 5. pii: 10.1007/s00125-022-05664.
    PubMed     Abstract available


  572. SIDDIQUI MK, Anjana RM, Dawed AY, Martoeau C, et al
    Young-onset diabetes in Asian Indians is associated with lower measured and genetically determined beta cell function.
    Diabetologia. 2022 Mar 5. pii: 10.1007/s00125-022-05671.
    PubMed     Abstract available


  573. FEVE B, Scheen AJ
    When therapeutic drugs lead to diabetes.
    Diabetologia. 2022 Mar 4. pii: 10.1007/s00125-022-05666.
    PubMed     Abstract available


  574. DOWNIE CG, Dimos SF, Bien SA, Hu Y, et al
    Multi-ethnic GWAS and fine-mapping of glycaemic traits identify novel loci in the PAGE Study.
    Diabetologia. 2022;65:477-489.
    PubMed     Abstract available


  575. GRAJALES D, Vazquez P, Ruiz-Rosario M, Tuduri E, et al
    The second-generation antipsychotic drug aripiprazole modulates the serotonergic system in pancreatic islets and induces beta cell dysfunction in female mice.
    Diabetologia. 2022;65:490-505.
    PubMed     Abstract available


    February 2022
  576. QIU Y, Buffonge S, Ramnath R, Jenner S, et al
    Endothelial glycocalyx is damaged in diabetic cardiomyopathy: angiopoietin 1 restores glycocalyx and improves diastolic function in mice.
    Diabetologia. 2022 Feb 25. pii: 10.1007/s00125-022-05650.
    PubMed     Abstract available


  577. SU MH, Shih YH, Lin YF, Chen PC, et al
    Familial aggregation and shared genetic loading for major psychiatric disorders and type 2 diabetes.
    Diabetologia. 2022 Feb 23. pii: 10.1007/s00125-022-05665.
    PubMed     Abstract available


  578. BENITEZ-AGUIRRE PZ, Marcovecchio ML, Chiesa ST, Craig ME, et al
    Urinary albumin/creatinine ratio tertiles predict risk of diabetic retinopathy progression: a natural history study from the Adolescent Cardio-Renal Intervention Trial (AdDIT) observational cohort.
    Diabetologia. 2022 Feb 19. pii: 10.1007/s00125-022-05661.
    PubMed     Abstract available


  579. FRASZCZYK E, Spijkerman AMW, Zhang Y, Brandmaier S, et al
    Epigenome-wide association study of incident type 2 diabetes: a meta-analysis of five prospective European cohorts.
    Diabetologia. 2022 Feb 15. pii: 10.1007/s00125-022-05652.
    PubMed     Abstract available


  580. JENKINS AJ, Grant MB, Busik JV
    Lipids, hyperreflective crystalline deposits and diabetic retinopathy: potential systemic and retinal-specific effect of lipid-lowering therapies.
    Diabetologia. 2022 Feb 11. pii: 10.1007/s00125-022-05655.
    PubMed     Abstract available


  581. TEO E, Hassan N, Tam W, Koh S, et al
    Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysis.
    Diabetologia. 2022 Feb 9. pii: 10.1007/s00125-021-05648.
    PubMed     Abstract available


  582. KIBIRIGE D, Sekitoleko I, Lumu W, Jones AG, et al
    Understanding the pathogenesis of lean non-autoimmune diabetes in an African population with newly diagnosed diabetes.
    Diabetologia. 2022 Feb 9. pii: 10.1007/s00125-021-05644.
    PubMed     Abstract available


  583. TUCHMAN AM
    One size does not fit all: an historian's perspective on precision diabetes medicine.
    Diabetologia. 2022 Feb 8. pii: 10.1007/s00125-022-05660.
    PubMed     Abstract available


  584. WALKER VM, Vujkovic M, Carter AR, Davies NM, et al
    Separating the direct effects of traits on atherosclerotic cardiovascular disease from those mediated by type 2 diabetes.
    Diabetologia. 2022 Feb 7. pii: 10.1007/s00125-022-05653.
    PubMed     Abstract available


  585. VANDERCAPPELLEN EJ, Koster A, Savelberg HHCM, Eussen SJPM, et al
    Sedentary behaviour and physical activity are associated with biomarkers of endothelial dysfunction and low-grade inflammation-relevance for (pre)diabetes: The Maastricht Study.
    Diabetologia. 2022 Feb 4. pii: 10.1007/s00125-022-05651.
    PubMed     Abstract available


  586. MIETTINEN ME, Honkanen J, Niinisto S, Vaarala O, et al
    Breastfeeding and circulating immunological markers during the first 3 years of life: the DIABIMMUNE study.
    Diabetologia. 2022;65:329-335.
    PubMed     Abstract available


    January 2022
  587. MOYCE GRUBER BL, Cole LK, Xiang B, Fonseca MA, et al
    Adiponectin deficiency induces hepatic steatosis during pregnancy and gestational diabetes in mice.
    Diabetologia. 2022 Jan 28. pii: 10.1007/s00125-021-05649.
    PubMed     Abstract available


  588. ZHAO JV, Liu F, Schooling CM, Li J, et al
    Using genetics to assess the association of commonly used antihypertensive drugs with diabetes, glycaemic traits and lipids: a trans-ancestry Mendelian randomisation study.
    Diabetologia. 2022 Jan 26. pii: 10.1007/s00125-021-05645.
    PubMed     Abstract available


  589. KHAN KS, Overgaard K, Tankisi H, Karlsson P, et al
    Effects of progressive resistance training in individuals with type 2 diabetic polyneuropathy: a randomised assessor-blinded controlled trial.
    Diabetologia. 2022 Jan 19. pii: 10.1007/s00125-021-05646.
    PubMed     Abstract available


  590. MURTHY VL, Nayor M, Carnethon M, Reis JP, et al
    Circulating metabolite profile in young adulthood identifies long-term diabetes susceptibility: the Coronary Artery Risk Development in Young Adults (CARDIA) study.
    Diabetologia. 2022 Jan 18. pii: 10.1007/s00125-021-05641.
    PubMed     Abstract available


  591. SO M, O'Rourke C, Ylescupidez A, Bahnson HT, et al
    Characterising the age-dependent effects of risk factors on type 1 diabetes progression.
    Diabetologia. 2022 Jan 18. pii: 10.1007/s00125-021-05647.
    PubMed     Abstract available


  592. DZIOPA K, Asselbergs FW, Gratton J, Chaturvedi N, et al
    Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings.
    Diabetologia. 2022 Jan 15. pii: 10.1007/s00125-021-05640.
    PubMed     Abstract available


  593. HO KL, Karwi QG, Connolly D, Pherwani S, et al
    Metabolic, structural and biochemical changes in diabetes and the development of heart failure.
    Diabetologia. 2022 Jan 7. pii: 10.1007/s00125-021-05637.
    PubMed     Abstract available


  594. THOMSEN MN, Skytte MJ, Samkani A, Carl MH, et al
    Dietary carbohydrate restriction augments weight loss-induced improvements in glycaemic control and liver fat in individuals with type 2 diabetes: a randomised controlled trial.
    Diabetologia. 2022 Jan 7. pii: 10.1007/s00125-021-05628.
    PubMed     Abstract available


  595. SORENSEN TIA, Metz S, Kilpelainen TO
    Do gene-environment interactions have implications for the precision prevention of type 2 diabetes?
    Diabetologia. 2022 Jan 7. pii: 10.1007/s00125-021-05639.
    PubMed     Abstract available


  596. HERDER C, Roden M
    A novel diabetes typology: towards precision diabetology from pathogenesis to treatment.
    Diabetologia. 2022 Jan 4. pii: 10.1007/s00125-021-05625.
    PubMed     Abstract available


  597. XIONG L, Chen L, Wu L, He W, et al
    Lipotoxicity-induced circGlis3 impairs beta cell function and is transmitted by exosomes to promote islet endothelial cell dysfunction.
    Diabetologia. 2022;65:188-205.
    PubMed     Abstract available


    December 2021
  598. BOCHKUR DRATVER MA, Arenas J, Thaweethai T, Yu C, et al
    Longitudinal changes in glucose during pregnancy in women with gestational diabetes risk factors.
    Diabetologia. 2021 Dec 30. pii: 10.1007/s00125-021-05622.
    PubMed     Abstract available


  599. SLUIMAN AJ, McLachlan S, Forster RB, Strachan MWJ, et al
    Higher baseline inflammatory marker levels predict greater cognitive decline in older people with type 2 diabetes: year 10 follow-up of the Edinburgh Type 2 Diabetes Study.
    Diabetologia. 2021 Dec 21. pii: 10.1007/s00125-021-05634.
    PubMed     Abstract available


  600. QUESADA-MASACHS E, Zilberman S, Rajendran S, Chu T, et al
    Upregulation of HLA class II in pancreatic beta cells from organ donors with type 1 diabetes.
    Diabetologia. 2021 Dec 21. pii: 10.1007/s00125-021-05619.
    PubMed     Abstract available


  601. YANG S, Yang G, Wu H, Kang L, et al
    MicroRNA-193b impairs muscle growth in mouse models of type 2 diabetes by targeting the PDK1/Akt signalling pathway.
    Diabetologia. 2021 Dec 16. pii: 10.1007/s00125-021-05616.
    PubMed     Abstract available


  602. STRELITZ J, Lawlor ER, Wu Y, Estlin A, et al
    Association between weight change and incidence of cardiovascular disease events and mortality among adults with type 2 diabetes: a systematic review of observational studies and behavioural intervention trials.
    Diabetologia. 2021 Dec 2. pii: 10.1007/s00125-021-05605.
    PubMed     Abstract available


  603. HOLT RIG, DeVries JH, Hess-Fischl A, Hirsch IB, et al
    Correction to: The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
    Diabetologia. 2021 Dec 1. pii: 10.1007/s00125-021-05600.
    PubMed    


  604. LIN DS, Lee JK, Hung CS, Chen WJ, et al
    The efficacy and safety of novel classes of glucose-lowering drugs for cardiovascular outcomes: a network meta-analysis of randomised clinical trials.
    Diabetologia. 2021;64:2676-2686.
    PubMed     Abstract available


  605. REMIE CME, Janssens GE, Bilet L, van Weeghel M, et al
    Sitting less elicits metabolic responses similar to exercise and enhances insulin sensitivity in postmenopausal women.
    Diabetologia. 2021;64:2817-2828.
    PubMed     Abstract available


  606. KARHUNEN V, Daghlas I, Zuber V, Vujkovic M, et al
    Leveraging human genetic data to investigate the cardiometabolic effects of glucose-dependent insulinotropic polypeptide signalling.
    Diabetologia. 2021;64:2773-2778.
    PubMed     Abstract available


    November 2021
  607. LINDEKILDE N, Scheuer SH, Rutters F, Knudsen L, et al
    Prevalence of type 2 diabetes in psychiatric disorders: an umbrella review with meta-analysis of 245 observational studies from 32 systematic reviews.
    Diabetologia. 2021 Nov 29. pii: 10.1007/s00125-021-05609.
    PubMed     Abstract available


  608. ALI MK, Pearson-Stuttard J, Selvin E, Gregg EW, et al
    Interpreting global trends in type 2 diabetes complications and mortality.
    Diabetologia. 2021 Nov 27. pii: 10.1007/s00125-021-05585.
    PubMed     Abstract available


  609. PRASAD RB, Asplund O, Shukla SR, Wagh R, et al
    Correction to: Subgroups of patients with young-onset type 2 diabetes in India reveal insulin deficiency as a major driver.
    Diabetologia. 2021 Nov 22. pii: 10.1007/s00125-021-05620.
    PubMed    


  610. CHENG F, Luk AO, Wu H, Tam CHT, et al
    Relative leucocyte telomere length is associated with incident end-stage kidney disease and rapid decline of kidney function in type 2 diabetes: analysis from the Hong Kong Diabetes Register.
    Diabetologia. 2021 Nov 22. pii: 10.1007/s00125-021-05613.
    PubMed     Abstract available


  611. PRESTON FG, Meng Y, Burgess J, Ferdousi M, et al
    Artificial intelligence utilising corneal confocal microscopy for the diagnosis of peripheral neuropathy in diabetes mellitus and prediabetes.
    Diabetologia. 2021 Nov 21. pii: 10.1007/s00125-021-05617.
    PubMed     Abstract available


  612. GRUBER N, Rathaus M, Ron I, Livne R, et al
    Fatty acid-binding protein 4: a key regulator of ketoacidosis in new-onset type 1 diabetes.
    Diabetologia. 2021 Nov 21. pii: 10.1007/s00125-021-05606.
    PubMed     Abstract available


  613. CHEN S, Zong G, Wu Q, Yun H, et al
    Associations of plasma glycerophospholipid profile with modifiable lifestyles and incident diabetes in middle-aged and older Chinese.
    Diabetologia. 2021 Nov 20. pii: 10.1007/s00125-021-05611.
    PubMed     Abstract available


  614. SOKOOTI S, Flores-Guerrero JL, Heerspink HJL, Garcia E, et al
    Lipoprotein particle sizes and incident type 2 diabetes: the PREVEND cohort study.
    Diabetologia. 2021 Nov 20. pii: 10.1007/s00125-021-05603.
    PubMed    


  615. MAALMI H, Herder C, Bonhof GJ, Strassburger K, et al
    Differences in the prevalence of erectile dysfunction between novel subgroups of recent-onset diabetes.
    Diabetologia. 2021 Nov 20. pii: 10.1007/s00125-021-05607.
    PubMed     Abstract available


  616. BEULENS JWJ, Pinho MGM, Abreu TC, den Braver NR, et al
    Environmental risk factors of type 2 diabetes-an exposome approach.
    Diabetologia. 2021 Nov 18. pii: 10.1007/s00125-021-05618.
    PubMed     Abstract available


  617. CHURUANGSUK C, Hall J, Reynolds A, Griffin SJ, et al
    Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission.
    Diabetologia. 2021 Nov 17. pii: 10.1007/s00125-021-05577.
    PubMed     Abstract available


  618. SECHER AL, Pedersen-Bjergaard U, Svendsen OL, Gade-Rasmussen B, et al
    Correction to: Flash glucose monitoring and automated bolus calculation in type 1 diabetes treated with multiple daily insulin injections: a 26 week randomised, controlled, multicentre trial.
    Diabetologia. 2021 Nov 15. pii: 10.1007/s00125-021-05601.
    PubMed    


  619. SPEIGHT J, Skinner TC, Huber JW, Lake AJ, et al
    A PSAD Group response to the consensus report on the definition and interpretation of remission in type 2 diabetes: a psychosocial perspective is needed.
    Diabetologia. 2021 Nov 15. pii: 10.1007/s00125-021-05615.
    PubMed    


  620. SUGIYAMA K, Saisho Y
    Predicting non-insulin-dependent state in patients with slowly progressive insulin-dependent (type 1) diabetes mellitus or latent autoimmune diabetes in adults.
    Diabetologia. 2021 Nov 11. pii: 10.1007/s00125-021-05602.
    PubMed    


  621. WADA E, Onoue T, Kinoshita T, Hayase A, et al
    Predicting non-insulin-dependent state in patients with slowly progressive insulin-dependent (type 1) diabetes mellitus or latent autoimmune diabetes in adults. Reply to Sugiyama K and Saisho Y [letter].
    Diabetologia. 2021 Nov 11. pii: 10.1007/s00125-021-05610.
    PubMed    


  622. DRAKE I, Fryk E, Strindberg L, Lundqvist A, et al
    The role of circulating galectin-1 in type 2 diabetes and chronic kidney disease: evidence from cross-sectional, longitudinal and Mendelian randomisation analyses.
    Diabetologia. 2021 Nov 7. pii: 10.1007/s00125-021-05594.
    PubMed     Abstract available


  623. STOTL I, Blagus R, Urbancic-Rovan V
    Individualised screening of diabetic foot: creation of a prediction model based on penalised regression and assessment of theoretical efficacy.
    Diabetologia. 2021 Nov 6. pii: 10.1007/s00125-021-05604.
    PubMed     Abstract available


  624. YAMAMOTO Y, Hanai K, Mori T, Yokoyama Y, et al
    Kidney outcomes and all-cause mortality in people with type 2 diabetes exhibiting non-albuminuric kidney insufficiency.
    Diabetologia. 2021 Nov 5. pii: 10.1007/s00125-021-05590.
    PubMed     Abstract available


  625. AMIRRUDDIN NS, Tan WX, Tan YS, Gardner DS, et al
    Progressive endoplasmic reticulum stress over time due to human insulin gene mutation contributes to pancreatic beta cell dysfunction.
    Diabetologia. 2021;64:2534-2549.
    PubMed     Abstract available


  626. VANDEWALLE J, Van der Auwera BJ, Amin H, Quartier E, et al
    Genetic variation at ERBB3/IKZF4 and sexual dimorphism in epitope spreading in single autoantibody-positive relatives.
    Diabetologia. 2021;64:2511-2516.
    PubMed     Abstract available


  627. YOUNG TK, Li JW, Kang A, Heerspink HJL, et al
    Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA1c, disease duration and treatment intensity: results from the CANVAS Program.
    Diabetologia. 2021;64:2402-2414.
    PubMed     Abstract available


    October 2021
  628. SCHLESINGER S, Neuenschwander M, Barbaresko J, Lang A, et al
    Prediabetes and risk of mortality, diabetes-related complications and comorbidities: umbrella review of meta-analyses of prospective studies.
    Diabetologia. 2021 Oct 31. pii: 10.1007/s00125-021-05592.
    PubMed     Abstract available


  629. CHARLES MH, Thomsen JL, Christensen B, Pulleyblank R, et al
    Use of electronic patient data overview with alerts in primary care increases prescribing of lipid-lowering medications in patients with type 2 diabetes.
    Diabetologia. 2021 Oct 28. pii: 10.1007/s00125-021-05598.
    PubMed     Abstract available


  630. CEREIJO L, Gullon P, Del Cura I, Valades D, et al
    Exercise facilities and the prevalence of obesity and type 2 diabetes in the city of Madrid.
    Diabetologia. 2021 Oct 28. pii: 10.1007/s00125-021-05582.
    PubMed     Abstract available


  631. BOLDISON J, Long AE, Aitken RJ, Wilson IV, et al
    Activated but functionally impaired memory Tregs are expanded in slow progressors to type 1 diabetes.
    Diabetologia. 2021 Oct 28. pii: 10.1007/s00125-021-05595.
    PubMed     Abstract available


  632. HELLER SR, Geybels MS, Iqbal A, Liu L, et al
    A higher non-severe hypoglycaemia rate is associated with an increased risk of subsequent severe hypoglycaemia and major adverse cardiovascular events in individuals with type 2 diabetes in the LEADER study.
    Diabetologia. 2021 Oct 26. pii: 10.1007/s00125-021-05556.
    PubMed     Abstract available


  633. THOMAS NJ, Dennis JM, Sharp SA, Kaur A, et al
    Correction to: DR15-DQ6 remains dominantly protective against type 1 diabetes throughout the first five decades of life.
    Diabetologia. 2021 Oct 26. pii: 10.1007/s00125-021-05599.
    PubMed    


  634. VETRANI C, Calabrese I, Cavagnuolo L, Pacella D, et al
    Dietary determinants of postprandial blood glucose control in adults with type 1 diabetes on a hybrid closed-loop system.
    Diabetologia. 2021 Oct 23. pii: 10.1007/s00125-021-05587.
    PubMed     Abstract available


  635. PRASAD RB, Asplund O, Shukla SR, Wagh R, et al
    Subgroups of patients with young-onset type 2 diabetes in India reveal insulin deficiency as a major driver.
    Diabetologia. 2021 Oct 23. pii: 10.1007/s00125-021-05543.
    PubMed     Abstract available


  636. PATEL KA, Ozbek MN, Yildiz M, Guran T, et al
    Systematic genetic testing for recessively inherited monogenic diabetes: a cross-sectional study in paediatric diabetes clinics.
    Diabetologia. 2021 Oct 23. pii: 10.1007/s00125-021-05597.
    PubMed     Abstract available


  637. MUTTER S, Valo E, Aittomaki V, Nybo K, et al
    Urinary metabolite profiling and risk of progression of diabetic nephropathy in 2670 individuals with type 1 diabetes.
    Diabetologia. 2021 Oct 22. pii: 10.1007/s00125-021-05584.
    PubMed     Abstract available


  638. LEMIEUX P, Benham JL, Donovan LE, Moledina N, et al
    The association between gestational diabetes and stillbirth: a systematic review and meta-analysis.
    Diabetologia. 2021 Oct 21. pii: 10.1007/s00125-021-05579.
    PubMed     Abstract available


  639. PIGEYRE M, Hess S, Gomez MF, Asplund O, et al
    Validation of the classification for type 2 diabetes into five subgroups: a report from the ORIGIN trial.
    Diabetologia. 2021 Oct 21. pii: 10.1007/s00125-021-05567.
    PubMed     Abstract available


  640. FARMAKI AE, Garfield V, Eastwood SV, Farmer RE, et al
    Type 2 diabetes risks and determinants in second-generation migrants and mixed ethnicity people of South Asian and African Caribbean descent in the UK.
    Diabetologia. 2021 Oct 20. pii: 10.1007/s00125-021-05580.
    PubMed     Abstract available


  641. AGYEMANG C, van der Linden EL, Bennet L
    Type 2 diabetes burden among migrants in Europe: unravelling the causal pathways.
    Diabetologia. 2021 Oct 16. pii: 10.1007/s00125-021-05586.
    PubMed     Abstract available


  642. JESUTHASAN A, Zhyzhneuskaya S, Peters C, Barnes AC, et al
    Sex differences in intraorgan fat levels and hepatic lipid metabolism: implications for cardiovascular health and remission of type 2 diabetes after dietary weight loss.
    Diabetologia. 2021 Oct 16. pii: 10.1007/s00125-021-05583.
    PubMed     Abstract available


  643. BENHALIMA K, van Nes F, Laenen A, Gillard P, et al
    Risk for ketonaemia in type 1 diabetes pregnancies with sensor-augmented pump therapy with predictive low glucose suspend compared with low glucose suspend: a crossover RCT.
    Diabetologia. 2021 Oct 13. pii: 10.1007/s00125-021-05589.
    PubMed     Abstract available


  644. FELTON JL, Cuthbertson D, Warnock M, Lohano K, et al
    HOMA2-B enhances assessment of type 1 diabetes risk among TrialNet Pathway to Prevention participants.
    Diabetologia. 2021 Oct 12. pii: 10.1007/s00125-021-05573.
    PubMed     Abstract available


  645. MORGENSTERN J, Groener JB, Jende JME, Kurz FT, et al
    Correction to: Neuron-specific biomarkers predict hypo- and hyperalgesia in individuals with diabetic peripheral neuropathy.
    Diabetologia. 2021 Oct 11. pii: 10.1007/s00125-021-05588.
    PubMed    


  646. LOCKE JM, Dusatkova P, Colclough K, Hughes AE, et al
    Association of birthweight and penetrance of diabetes in individuals with HNF4A-MODY: a cohort study.
    Diabetologia. 2021 Oct 7. pii: 10.1007/s00125-021-05581.
    PubMed    


  647. JEYAM A, Gibb FW, McKnight JA, O'Reilly JE, et al
    Flash monitor initiation is associated with improvements in HbA1c levels and DKA rates among people with type 1 diabetes in Scotland: a retrospective nationwide observational study.
    Diabetologia. 2021 Oct 7. pii: 10.1007/s00125-021-05578.
    PubMed     Abstract available


  648. GREEN A, Hede SM, Patterson CC, Wild SH, et al
    Type 1 diabetes in 2017: global estimates of incident and prevalent cases in children and adults.
    Diabetologia. 2021 Oct 2. pii: 10.1007/s00125-021-05571.
    PubMed     Abstract available


  649. SEN T, Li J, Neuen BL, Neal B, et al
    Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trial.
    Diabetologia. 2021;64:2147-2158.
    PubMed     Abstract available


  650. PERNG W, Kelsey MM, Sauder KA, Dabelea D, et al
    How does exposure to overnutrition in utero lead to childhood adiposity? Testing the insulin hypersecretion hypothesis in the EPOCH cohort.
    Diabetologia. 2021;64:2237-2246.
    PubMed     Abstract available


  651. UEDA P, Wintzell V, Melbye M, Eliasson B, et al
    Use of incretin-based drugs and risk of cholangiocarcinoma: Scandinavian cohort study.
    Diabetologia. 2021;64:2204-2214.
    PubMed     Abstract available


  652. JENSEN MH, Hejlesen O, Vestergaard P
    Epidemiology of hypoglycaemic episodes leading to hospitalisations in Denmark in 1998-2018.
    Diabetologia. 2021;64:2193-2203.
    PubMed     Abstract available


    September 2021
  653. BARROSO I
    The importance of increasing population diversity in genetic studies of type 2 diabetes and related glycaemic traits.
    Diabetologia. 2021 Sep 30. pii: 10.1007/s00125-021-05575.
    PubMed     Abstract available


  654. HOLT RIG, DeVries JH, Hess-Fischl A, Hirsch IB, et al
    The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
    Diabetologia. 2021 Sep 30. pii: 10.1007/s00125-021-05568.
    PubMed     Abstract available


  655. RUSSELL RD, Roberts-Thomson KM, Hu D, Greenaway T, et al
    Impaired postprandial skeletal muscle vascular responses to a mixed meal challenge in normoglycaemic people with a parent with type 2 diabetes.
    Diabetologia. 2021 Sep 29. pii: 10.1007/s00125-021-05572.
    PubMed     Abstract available


  656. SIDDIQUI MK, Smith G, St Jean P, Dawed AY, et al
    Diabetes status modifies the long-term effect of lipoprotein-associated phospholipase A2 on major coronary events.
    Diabetologia. 2021 Sep 25. pii: 10.1007/s00125-021-05574.
    PubMed     Abstract available


  657. SJOGREN RJO, Rizo-Roca D, Chibalin AV, Chorell E, et al
    Branched-chain amino acid metabolism is regulated by ERRalpha in primary human myotubes and is further impaired by glucose loading in type 2 diabetes.
    Diabetologia. 2021;64:2077-2091.
    PubMed     Abstract available


  658. QIAN B, Yang Y, Tang N, Wang J, et al
    M1 macrophage-derived exosomes impair beta cell insulin secretion via miR-212-5p by targeting SIRT2 and inhibiting Akt/GSK-3beta/beta-catenin pathway in mice.
    Diabetologia. 2021;64:2037-2051.
    PubMed     Abstract available


  659. MOHOLDT T, Parr EB, Devlin BL, Debik J, et al
    The effect of morning vs evening exercise training on glycaemic control and serum metabolites in overweight/obese men: a randomised trial.
    Diabetologia. 2021;64:2061-2076.
    PubMed     Abstract available


    August 2021
  660. HENRIKSEN MM, Andersen HU, Thorsteinsson B, Pedersen-Bjergaard U, et al
    Does nocturnal hypoglycaemia really improve quality of life? Reply to Soholm U, Broadley MM, Choudhary P et al [letter].
    Diabetologia. 2021;64:1895-1896.
    PubMed    


  661. FOREMAN YD, van Doorn WPTM, Schaper NC, van Greevenbroek MMJ, et al
    Greater daily glucose variability and lower time in range assessed with continuous glucose monitoring are associated with greater aortic stiffness: The Maastricht Study.
    Diabetologia. 2021;64:1880-1892.
    PubMed     Abstract available


  662. REID LJ, Gibb FW, Colhoun H, Wild SH, et al
    Continuous subcutaneous insulin infusion therapy is associated with reduced retinopathy progression compared with multiple daily injections of insulin.
    Diabetologia. 2021;64:1725-1736.
    PubMed     Abstract available


  663. SCHNURR TM, Jorsboe E, Chadt A, Dahl-Petersen IK, et al
    Physical activity attenuates postprandial hyperglycaemia in homozygous TBC1D4 loss-of-function mutation carriers.
    Diabetologia. 2021;64:1795-1804.
    PubMed     Abstract available


    July 2021
  664. GASTALDELLI A, Stefan N, Haring HU
    Liver-targeting drugs and their effect on blood glucose and hepatic lipids.
    Diabetologia. 2021;64:1461-1479.
    PubMed     Abstract available


  665. BENN M, Emanuelsson F, Tybjaerg-Hansen A, Nordestgaard BG, et al
    Impact of high glucose levels and glucose lowering on risk of ischaemic stroke: a Mendelian randomisation study and meta-analysis.
    Diabetologia. 2021;64:1492-1503.
    PubMed     Abstract available


  666. KRISTENSEN KB, Henriksen DP, Hallas J, Pottegard A, et al
    Sodium-glucose cotransporter 2 inhibitors and risk of nephrolithiasis.
    Diabetologia. 2021;64:1563-1571.
    PubMed     Abstract available


    June 2021
  667. FRANCIS EC, Dabelea D, Perng W
    Impact of maternal HbA1c on offspring glucose at 4-7 years of age: role of childhood adiposity and other potential confounders. Reply to Periyathambi N, Sukumar N, Weldeselassie Y, Saravanan P [letter].
    Diabetologia. 2021;64:1449-1450.
    PubMed    


  668. PERIYATHAMBI N, Sukumar N, Weldeselassie Y, Saravanan P, et al
    Impact of maternal HbA1c on offspring glucose at 4-7 years of age: role of childhood adiposity and other potential confounders.
    Diabetologia. 2021;64:1447-1448.
    PubMed    


  669. GERST F, Kemter E, Lorza-Gil E, Kaiser G, et al
    The hepatokine fetuin-A disrupts functional maturation of pancreatic beta cells.
    Diabetologia. 2021;64:1358-1374.
    PubMed     Abstract available


  670. RATHMANN W, Bongaerts B
    Pharmacogenetics of novel glucose-lowering drugs.
    Diabetologia. 2021;64:1201-1212.
    PubMed     Abstract available


    May 2021
  671. MARSHALL SM
    Celebrating 100 years of insulin.
    Diabetologia. 2021;64:944-946.
    PubMed    


  672. JAROSINSKI MA, Dhayalan B, Rege N, Chatterjee D, et al
    'Smart' insulin-delivery technologies and intrinsic glucose-responsive insulin analogues.
    Diabetologia. 2021;64:1016-1029.
    PubMed     Abstract available


  673. AMIEL SA
    The consequences of hypoglycaemia.
    Diabetologia. 2021;64:963-970.
    PubMed     Abstract available


  674. BOUGHTON CK, Hovorka R
    New closed-loop insulin systems.
    Diabetologia. 2021;64:1007-1015.
    PubMed     Abstract available


  675. NATHAN DM
    Realising the long-term promise of insulin therapy: the DCCT/EDIC study.
    Diabetologia. 2021;64:1049-1058.
    PubMed     Abstract available


  676. YOON NA, Diano S
    Hypothalamic glucose-sensing mechanisms.
    Diabetologia. 2021;64:985-993.
    PubMed     Abstract available


  677. BERAN D, Lazo-Porras M, Mba CM, Mbanya JC, et al
    A global perspective on the issue of access to insulin.
    Diabetologia. 2021;64:954-962.
    PubMed     Abstract available


  678. MELTON D
    The promise of stem cell-derived islet replacement therapy.
    Diabetologia. 2021;64:1030-1036.
    PubMed     Abstract available


  679. MATHIEU C
    Minimising hypoglycaemia in the real world: the challenge of insulin.
    Diabetologia. 2021;64:978-984.
    PubMed     Abstract available


    April 2021
  680. MOSER O, Riddell MC, Eckstein ML, Adolfsson P, et al
    Glucose management for exercise using continuous glucose monitoring: should sex and prandial state be additional considerations? Reply to Yardley JE and Sigal RJ [letter].
    Diabetologia. 2021;64:935-938.
    PubMed    


  681. YARDLEY JE, Sigal RJ
    Glucose management for exercise using continuous glucose monitoring: should sex and prandial state be additional considerations?
    Diabetologia. 2021;64:932-934.
    PubMed    


  682. HUGHES AE, Hattersley AT, Flanagan SE, Freathy RM, et al
    Two decades since the fetal insulin hypothesis: what have we learned from genetics?
    Diabetologia. 2021;64:717-726.
    PubMed     Abstract available


  683. FABRICIUS TW, Verhulst CEM, Kristensen PL, Tack CJ, et al
    Hyperinsulinaemic-hypoglycaemic glucose clamps in human research: a systematic review of the literature.
    Diabetologia. 2021;64:727-736.
    PubMed     Abstract available


  684. AKAZAWA S, Mackin L, Jhala G, Fynch S, et al
    Deficiency of the innate immune adaptor STING promotes autoreactive T cell expansion in NOD mice.
    Diabetologia. 2021;64:878-889.
    PubMed     Abstract available


    March 2021
  685. AMIYA T, Nakamoto N, Irie J, Taniki N, et al
    C-C motif chemokine receptor 9 regulates obesity-induced insulin resistance via inflammation of the small intestine in mice.
    Diabetologia. 2021;64:603-617.
    PubMed     Abstract available


    February 2021
  686. HOUZELLE A, Jorgensen JA, Schaart G, Daemen S, et al
    Human skeletal muscle mitochondrial dynamics in relation to oxidative capacity and insulin sensitivity.
    Diabetologia. 2021;64:424-436.
    PubMed     Abstract available


  687. ELEFTHERIADOU A, Williams S, Nevitt S, Brown E, et al
    The prevalence of cardiac autonomic neuropathy in prediabetes: a systematic review.
    Diabetologia. 2021;64:288-303.
    PubMed     Abstract available


  688. MADSEN LR, Gibbons KS, Ma RCW, Tam WH, et al
    Do variations in insulin sensitivity and insulin secretion in pregnancy predict differences in obstetric and neonatal outcomes?
    Diabetologia. 2021;64:304-312.
    PubMed     Abstract available


  689. PILMARK NS, Lyngbaek M, Oberholzer L, Elkjaer I, et al
    The interaction between metformin and physical activity on postprandial glucose and glucose kinetics: a randomised, clinical trial.
    Diabetologia. 2021;64:397-409.
    PubMed     Abstract available


    January 2021
  690. MULDER H
    The times they are a-changin'.
    Diabetologia. 2021;64:3-4.
    PubMed    


  691. KAHN D, Perreault L, Macias E, Zarini S, et al
    Subcellular localisation and composition of intramuscular triacylglycerol influence insulin sensitivity in humans.
    Diabetologia. 2021;64:168-180.
    PubMed     Abstract available


  692. FAERCH K, Blond MB, Bruhn L, Amadid H, et al
    The effects of dapagliflozin, metformin or exercise on glycaemic variability in overweight or obese individuals with prediabetes (the PRE-D Trial): a multi-arm, randomised, controlled trial.
    Diabetologia. 2021;64:42-55.
    PubMed     Abstract available


    May 2020
  693. CHE D, Fang Z, Yan L, Du J, et al
    Elevated pigment epithelium-derived factor induces diabetic erectile dysfunction via interruption of the Akt/Hsp90beta/eNOS complex.
    Diabetologia. 2020 May 6. pii: 10.1007/s00125-020-05147.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.